<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Diabetes Res</journal-id><journal-id journal-id-type="iso-abbrev">J Diabetes Res</journal-id><journal-id journal-id-type="publisher-id">JDR</journal-id><journal-title-group><journal-title>Journal of Diabetes Research</journal-title></journal-title-group><issn pub-type="ppub">2314-6745</issn><issn pub-type="epub">2314-6753</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5476901</article-id><article-id pub-id-type="doi">10.1155/2017/1789395</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Muscle Lipid Metabolism: Role of Lipid Droplets and Perilipins</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Morales</surname><given-names>Pablo Esteban</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4990-3385</contrib-id><name><surname>Bucarey</surname><given-names>Jose Luis</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4779-5341</contrib-id><name><surname>Espinosa</surname><given-names>Alejandra</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Departamento de Tecnolog&#x000ed;a M&#x000e9;dica, Facultad de Medicina, Universidad de Chile, Santiago, Chile</aff><aff id="I2"><sup>2</sup>CIDIS-AC, Escuela de Medicina, Universidad de Valparaiso, Valparaiso, Chile</aff><aff id="I3"><sup>3</sup>Center for Molecular Studies of the Cell, Facultad de Medicina, Universidad de Chile, Santiago, Chile</aff><author-notes><corresp id="cor1">*Alejandra Espinosa: <email>bespinosa@med.uchile.cl</email></corresp><fn fn-type="other"><p>Academic Editor: Erick O. Hern&#x000e1;ndez-Ochoa</p></fn></author-notes><pub-date pub-type="ppub"><year>2017</year></pub-date><pub-date pub-type="epub"><day>6</day><month>6</month><year>2017</year></pub-date><volume>2017</volume><elocation-id>1789395</elocation-id><history><date date-type="received"><day>6</day><month>1</month><year>2017</year></date><date date-type="rev-recd"><day>19</day><month>4</month><year>2017</year></date><date date-type="accepted"><day>26</day><month>4</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 Pablo Esteban Morales et al.</copyright-statement><copyright-year>2017</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Skeletal muscle is one of the main regulators of carbohydrate and lipid metabolism in our organism, and therefore, it is highly susceptible to changes in glucose and fatty acid (FA) availability. Skeletal muscle is an extremely complex tissue: its metabolic capacity depends on the type of fibers it is made up of and the level of stimulation it undergoes, such as acute or chronic contraction. Obesity is often associated with increased FA levels, which leads to the accumulation of toxic lipid intermediates, oxidative stress, and autophagy in skeletal fibers. This lipotoxicity is one of the most common causes of insulin resistance (IR). In this scenario, the &#x0201c;isolation&#x0201d; of certain lipids in specific cell compartments, through the action of the specific lipid droplet, perilipin (PLIN) family of proteins, is conceived as a lifeguard compensatory strategy. In this review, we summarize the cellular mechanism underlying lipid mobilization and metabolism inside skeletal muscle, focusing on the function of lipid droplets, the PLIN family of proteins, and how these entities are modified in exercise, obesity, and IR conditions.</p></abstract><funding-group><award-group><funding-source>National Fund for Scientific and Technological Development</funding-source><award-id>1151293</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Obesity and type 2 diabetes mellitus (T2DM) have become hallmark pandemic events of our century, currently affecting 600 million [<xref rid="B1" ref-type="bibr">1</xref>] and 380 million adult people [<xref rid="B2" ref-type="bibr">2</xref>], respectively. These pathologies have a longstanding stablished relation, as obese patients are often diabetic as well [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>]. Increased free fatty acid (FFA) plasma levels are present in both pathologies [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>], and therefore, they have been conceived as a major link between obesity and T2DM.</p><p>T2DM is a disorder of variable etiology characterized by sustained hyperglycemia, with alterations of carbohydrate, fat, and protein metabolism [<xref rid="B7" ref-type="bibr">7</xref>]. In the case of T2DM, this overt hyperglycemia results from the reduced action of insulin on its target tissues, such as skeletal muscle, liver, and adipose tissue, at least on initial stages [<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>]. In this regard, the proper function of skeletal muscle is of paramount importance, given that it is involved in the clearance of 25% of plasmatic glucose in a basal, fasting state [<xref rid="B8" ref-type="bibr">8</xref>] and up to nearly 70&#x02013;85% of plasmatic glucose in postprandial state [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>]. This substantial increment in skeletal muscle glucose uptake is the result of increased presence of the facilitative glucose transporter 4 (GLUT4) in the sarcolemma and T-tubule in response to insulin action. This transporter is basally located in intracellular vesicles and moves to and fuses with the plasma membrane as a result of insulin-mediated signaling [<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>]. The particularities of glucose transport, kinetics, and mechanisms are beyond the scope of this review and can be read elsewhere [<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>].</p><p>As mentioned before, alteration of FA metabolism is also an important feature of T2DM patients, as their plasmatic levels are often increased [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B16" ref-type="bibr">16</xref>]. However, different lines of evidence have indicated that accumulation of different lipidic entities inside muscle cells leads to insulin resistance. Increased ceramide [<xref rid="B17" ref-type="bibr">17</xref>], intramyocellular lipids (IMCLs) [<xref rid="B18" ref-type="bibr">18</xref>], diacylglycerol (DAG) [<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>], and long-chain fatty acyl-CoA [<xref rid="B21" ref-type="bibr">21</xref>] levels have been negatively correlated with insulin action, depicting the importance of understanding the link between obesity and the lack of insulin response in skeletal muscle. The mechanisms involved in intracellular lipid accumulation and how these phenomena are involved in IR is relevant to understand the extent of obesity-induced damage in skeletal muscle. In this review, we begin with a comprehensive view of lipid metabolism in healthy skeletal muscle, covering uptake, metabolization, and storage. We then focus on the function of lipid droplets (LDs), an organelle responsible for both intracellular storage and trafficking of FAs between different cellular compartments, and provide information on how LDs contribute to insulin resistance in the obese state, with special interest on specific LD proteins, the PLIN protein family.</p></sec><sec id="sec2"><title>2. Overview of Lipid Metabolism in Healthy Skeletal Muscle</title><p>Skeletal muscle is responsible for the body's energy expenditure, participating in thermogenic functions, glucose and lipid uptake, and other metabolic processes. The fuel supply is obtained from metabolic machinery involving enzymatic pathways in charge of obtaining energy from glucose and FAs, through glycolysis and <italic>&#x003b2;</italic>-oxidation, respectively. These processes are dependent on substrate availability [<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>].</p><p>Lipolysis is the process in which triacylglycerides (TAGs) are broken down to produce FFAs. Increased FA turnover is triggered by various stimuli, including <italic>&#x003b2;</italic>-adrenergic agonists and exercise [<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>]. FA uptake in the muscle is dependent on metabolic demands and lipid availability. Once inside the cell, FAs enter the oxidative process, TAG synthesis, or if uptake exceeds metabolization, they undergo accumulation in confined compartments, often LD. Acute lipid oversupply produces inhibition of glucose oxidation, and mitochondria preferentially switch from carbohydrate to FA utilization, depicting the high degree of metabolic flexibility in skeletal muscle [<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>]. In fact, the sole alteration of FA entrance machinery levels is able to modulate FA oxidation rate [<xref rid="B28" ref-type="bibr">28</xref>] indicating a high level of metabolic interregulation. <xref ref-type="fig" rid="fig1"> Figure 1</xref> depicts the key points regarding FA flux inside skeletal muscle cells, as will be discussed in the following sections.</p><sec id="sec2.1"><title>2.1. Lipid Uptake</title><p>FAs move from plasma into skeletal fibers using different proteins, such as FA binding proteins [<xref rid="B29" ref-type="bibr">29</xref>] and FA transport proteins (FATPs) [<xref rid="B30" ref-type="bibr">30</xref>]. All of these proteins are upregulated by classic stimuli that are often associated to skeletal muscle: insulin and contraction [<xref rid="B31" ref-type="bibr">31</xref>&#x02013;<xref rid="B33" ref-type="bibr">33</xref>]. For instance, FA translocase (also known as cluster of differentiation 36, CD36), which translocates from cytoplasm to plasma membrane in specialized vesicles, is able to relocate in response to muscle contractions [<xref rid="B34" ref-type="bibr">34</xref>]. Furthermore, CD36 mRNA and protein levels are upregulated by high-lipid diet feeding, increasing FA uptake in skeletal muscle [<xref rid="B35" ref-type="bibr">35</xref>]. As for FATPs, these proteins are expressed in a tissue-specific manner, with FATP1, FATP4, and FATP6 variants being the predominant forms in skeletal muscle [<xref rid="B36" ref-type="bibr">36</xref>]. Its function is still debated, as they have been also shown to possess enzymatic activity (as acyl-CoA synthetases), besides its transport function [<xref rid="B37" ref-type="bibr">37</xref>]. FATP1 is present in T-tubules, and its overexpression has been shown to increase FA oxidation in skeletal muscle [<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>]. After contraction, FATP4 and CD36 are both increased in the sarcolemma, while insulin stimulation induces the translocation of FATP1 and FATP4 to the T-tubules, increasing FA uptake [<xref rid="B38" ref-type="bibr">38</xref>].</p><p>Once FAs enter the skeletal fiber, they have different fates depending on the metabolic status of the cells. In resting condition, plasma FAs are driven into TAG synthesis as the first destination instead of being moved to the mitochondria for oxidation [<xref rid="B40" ref-type="bibr">40</xref>].</p></sec><sec id="sec2.2"><title>2.2. Lipid Storage</title><p>Increased lipid deposition in skeletal muscle develops when skeletal fiber FA uptake outpaces FA oxidation. An excessive lipid flux into the skeletal muscle is a factor that influences the accumulation of lipid intermediates, which in turn produces lipotoxic stress [<xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>]. Lipid excess generates fatty infiltrations, also called intermuscular adipose tissue, and IMCLs. Evidence suggests that intermuscular adipose tissue is related to the aging process, loss of muscle strength, and decrease in muscle insulin sensitivity [<xref rid="B43" ref-type="bibr">43</xref>]. IMCLs are stored in LDs localized between the sarcomeres and adjacent to mitochondria [<xref rid="B44" ref-type="bibr">44</xref>], providing an energy pool used in acute and chronic exercise, as will be discussed in the next sections.</p><p>IMCLs are composed of triacylglycerol, diacylglycerol (DAG), long-chain acyl-CoA, and ceramides and both DAGs and ceramides are implicated in muscle lipotoxic effect [<xref rid="B45" ref-type="bibr">45</xref>]. As mentioned earlier, IMCL accumulation is associated with alterations in insulin signaling [<xref rid="B18" ref-type="bibr">18</xref>]. It is worth noting, however, that IMCLs are not always related to obesity. In healthy subjects, women can accumulate 57% more lipids than men in skeletal tissue, without being obese [<xref rid="B46" ref-type="bibr">46</xref>]. Hoeg et al. suggested that there is not a clear association between TAG content and impairment of insulin-stimulated muscle glucose uptake [<xref rid="B46" ref-type="bibr">46</xref>]. Indeed, accumulation of LDs is often present in endurance athletes [<xref rid="B47" ref-type="bibr">47</xref>], who have functional insulin signaling. This phenomenon is known as the &#x0201c;athlete's paradox,&#x0201d; and its mechanism remains unclear [<xref rid="B48" ref-type="bibr">48</xref>].</p><p>Several lines of evidence show that elevated lipid intermediates such as DAGs and ceramides are associated with impaired insulin signaling in skeletal muscle [<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B49" ref-type="bibr">49</xref>&#x02013;<xref rid="B51" ref-type="bibr">51</xref>]. Curiously, DAGs are also higher in trained athletes, which were associated with improved insulin sensitivity [<xref rid="B52" ref-type="bibr">52</xref>], suggesting that DAG content is not always indicative of insulin signaling derangement.</p></sec><sec id="sec2.3"><title>2.3. Lipolysis in Skeletal Muscle</title><p>There are three lipases expressed in skeletal muscle that are responsible for the breakdown of TAGs: monoacylglycerol lipase, adipose triglyceride lipase (ATGL), and hormone-sensitive lipase (HSL) [<xref rid="B53" ref-type="bibr">53</xref>]. ATGL catalyzes the first step of TAG lipolysis in skeletal muscle from humans and mice, resulting in the release of one fatty acid molecule. Monoacylglycerol lipase is responsible for the hydrolysis of monoacylglycerol, releasing glycerol and FAs. Overexpression of ATGL in skeletal muscle cells generates an increase in lipolysis and in the expression of the transcription factor PPAR<italic>&#x003b4;</italic>, suggesting a role of ATGL in mitochondrial biogenesis [<xref rid="B54" ref-type="bibr">54</xref>]. This in turn is associated with increased oxidative capacity in skeletal muscle [<xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B55" ref-type="bibr">55</xref>]. Endurance training leads to increased ATGL levels, enhancing intramuscular lipolysis, mainly in type I oxidative fibers [<xref rid="B56" ref-type="bibr">56</xref>]. On the contrary, a decrease in ATGL expression characterizes aged muscle, which is accompanied by defects in the antioxidant response and sarcopenia [<xref rid="B57" ref-type="bibr">57</xref>].</p><p>ATGL is activated by comparative gene identification-58 (CGI-58), a protein member of <italic>&#x003b1;</italic>/<italic>&#x003b2;</italic>-hydrolase fold enzyme family [<xref rid="B58" ref-type="bibr">58</xref>]. These proteins are located on the surface of LDs and mitochondria [<xref rid="B59" ref-type="bibr">59</xref>], CGI-58 being preferentially expressed in oxidative muscle, as cardiac and soleus muscle [<xref rid="B60" ref-type="bibr">60</xref>]. The increase in lipolytic activity results from direct interaction between CGI-58 and ATGL [<xref rid="B58" ref-type="bibr">58</xref>]. CGI-58 knockdown reduces lipolysis and incorporation of FAs into TAGs, along with reducing mitochondrial membrane potential [<xref rid="B60" ref-type="bibr">60</xref>]. Likewise, muscle-specific inactivation of CGI-58 in mice induces skeletal steatosis but only in oxidative muscle [<xref rid="B61" ref-type="bibr">61</xref>]. It is not surprising then that CGI-58 mutations produce lipid storage diseases, such as the Chanarin-Dorfman syndrome, which is characterized by neutral lipid accumulation in skeletal muscle and ichthyosis [<xref rid="B62" ref-type="bibr">62</xref>]. Interestingly, Xie et al. found that diminished CGI-58 levels improve glucose tolerance and insulin sensitivity in mice fed with high-fat diet (HFD). The authors explain these findings by suggesting that storing fat in glycolytic muscle is detrimental, whereas it is healthy in oxidative muscle [<xref rid="B61" ref-type="bibr">61</xref>].</p><p>Similar to ATGL, HSL catalyzes TAG hydrolysis to release FAs into the cytoplasm. Like CGI-58, HSL is highly expressed in type I oxidative fibers of skeletal muscle, and it is activated by adrenergic stimulation and contraction [<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>]. Both stimuli are capable of regulating HSL activity through PKA- and AMPK-dependent phosphorylation, thus modulating the breakdown of TAGs from IMTG [<xref rid="B65" ref-type="bibr">65</xref>].</p></sec></sec><sec id="sec3"><title>3. Role of Lipid Droplets and Perilipins</title><p>As shown in the previous sections, FA metabolism in skeletal muscle requires a tight balance between the uptake and usage processes, to avoid accumulation of detrimental lipid intermediaries. In this regard, LDs play a pivotal role in maintaining intracellular lipid homeostasis.</p><p>LDs are intracellular vesicle-like organelles composed mainly of neutral lipids, including TAGs and sterol esters (<xref ref-type="fig" rid="fig1">Figure 1(a)</xref>), and are present in different cellular types, with adipose tissue and skeletal muscle being the most studied [<xref rid="B66" ref-type="bibr">66</xref>]. Its formation is a consequence of different metabolic processes, such as lipid storage, lipid exchange between organelles, and cell signaling. LDs are limited by a phospholipid monolayer, which includes phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol [<xref rid="B67" ref-type="bibr">67</xref>]. This composition is similar to the endoplasmic reticulum (ER) membrane, supporting the idea that LDs are a specialized domain of the ER [<xref rid="B68" ref-type="bibr">68</xref>].</p><p>LDs are covered with different members of lipid droplet-associating protein family, referred as the PAT family [<xref rid="B69" ref-type="bibr">69</xref>]. This family is composed of perilipins (PLINs), S3-12, and TIP47, among other proteins, which vary on tissue-specific expression and their constitutive or differentiated permanence on LD surface [<xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B71" ref-type="bibr">71</xref>]. The most characterized members of the PAT family are PLINs, which are discussed in detail below.</p><p>Perilipin family is composed by 5 members (PLIN1&#x02013;5) that play a major role in the control of TAG hydrolysis and lipolysis in adipose tissue, with a less clear role in skeletal muscle. PLIN1 is expressed in adipocytes and steroidogenic cells but not in skeletal muscle [<xref rid="B72" ref-type="bibr">72</xref>, <xref rid="B73" ref-type="bibr">73</xref>], and therefore, its function is not further discussed.</p><p>On the other hand, PLIN2 is highly expressed in adipose tissue and skeletal muscle in both rodents and humans [<xref rid="B74" ref-type="bibr">74</xref>]. The levels of this protein correlate positively with LD content in skeletal muscle [<xref rid="B74" ref-type="bibr">74</xref>], where it can interact with ATGL [<xref rid="B75" ref-type="bibr">75</xref>] and HSL [<xref rid="B76" ref-type="bibr">76</xref>]. PLIN2 is necessary for both differentiation and regulation of lipolysis in adipose tissue, but its role in skeletal muscle remains unclear. Overexpression of PLIN2 results in increased intracellular TAG storage and larger and more numerous LDs in tibialis anterior muscle [<xref rid="B77" ref-type="bibr">77</xref>]. In agreement, downregulation of PLIN2 in cultured myotubes prevented oleate-induced lipid droplet storage, suggesting its involvement in LD stabilization [<xref rid="B77" ref-type="bibr">77</xref>]. Evidence suggests that PLIN2 participates in IMCL synthesis and LD growth (<xref ref-type="fig" rid="fig1">Figure 1(b)</xref>), but it seems that it is not implicated in skeletal muscle lipolysis, as PLIN2 is not phosphorylated under adrenergic or contractile stimulation [<xref rid="B76" ref-type="bibr">76</xref>]. Interestingly, PLIN2-coated LDs increase with age and are associated with lack of muscle strength [<xref rid="B78" ref-type="bibr">78</xref>]. This is interesting, as aging is associated with insulin resistance [<xref rid="B79" ref-type="bibr">79</xref>].</p><p>Unlike PLIN2, the role of PLIN3 in skeletal muscle is not clear. Pharmacological and genetic activation of AMP-activated protein kinase leads to increased gene expression of PLIN3 in skeletal muscle, resulting in higher IMCL content [<xref rid="B80" ref-type="bibr">80</xref>]. Conversely, PLIN3 levels in muscle biopsies from healthy patients are positively correlated with whole-body oxidative capacity, while PLIN3 knockdown results in decreased FA oxidation [<xref rid="B81" ref-type="bibr">81</xref>]. Subcellular localization of PLIN3 may play a role in its function, as it has been observed that endurance training, but not electrically induced contraction, induces PLIN3 expression and its association with mitochondria in rats (<xref ref-type="fig" rid="fig1">Figure 1(c)</xref>) [<xref rid="B82" ref-type="bibr">82</xref>]. Whether species-specific function or intracellular localization is responsible for this discrepancy is still unknown.</p><p>Little is known about PLIN4 in skeletal muscle. This perilipin is expressed in skeletal muscle, heart, and adipose tissue, and it is preferentially located in LDs containing cholesterol esters [<xref rid="B83" ref-type="bibr">83</xref>]. Of all perilipins, <italic>Plin4</italic> mRNA is the most expressed in vastus lateralis biopsies from healthy individuals, and its levels are higher in slow- than fast-twitch muscle [<xref rid="B84" ref-type="bibr">84</xref>]. Unlike PLIN3, PLIN4 expression is reduced in response to prolonged endurance training [<xref rid="B84" ref-type="bibr">84</xref>].</p><p>PLIN5 is found both on the surface of LDs and in the cytoplasm, and it is transcriptionally regulated by PPAR<italic>&#x003b4;</italic> in skeletal muscle. PLIN5 is highly expressed in oxidative tissue such as cardiac and skeletal muscle [<xref rid="B85" ref-type="bibr">85</xref>]. Laurens et al. conclude that PLIN5 has an important role in lipolysis, facilitating FA oxidation in response to contraction and increased metabolic demand [<xref rid="B86" ref-type="bibr">86</xref>]. PLIN5 is involved in the communication between the LDs and the mitochondria, presumably to facilitate the direct transfer of FFAs released during lipolysis (<xref ref-type="fig" rid="fig1">Figure 1(c)</xref>). In fact, there is close structural proximity between PLIN5-decorated LDs and mitochondria [<xref rid="B87" ref-type="bibr">87</xref>] and PLIN5 overexpression leads to increased transcription of mitochondrial biogenesis, electron transport chain complexes, and FA oxidation genes [<xref rid="B88" ref-type="bibr">88</xref>]. PLIN5 overexpression increases both expression and serum concentration of fibroblast growth factor 21, a major insulin- and exercise-responsive myokine [<xref rid="B89" ref-type="bibr">89</xref>]. Furthermore, its overexpression can induce gene expression of factors involved in the ER stress response in order to preserve mitochondrial function [<xref rid="B89" ref-type="bibr">89</xref>].</p></sec><sec id="sec4"><title>4. Lipid Droplet Remodeling in Skeletal Muscle after Contraction</title><p>Skeletal muscle is a plastic tissue susceptible to different stimuli but mainly adrenergic stimulation and contraction. Studies have been designed to evaluate PLIN distribution after contraction-induced muscle lipolysis in skeletal muscle, in order to understand the physiological role of PLINs in metabolism. The mechanisms that regulate exercise-induced lipolysis in skeletal muscle are poorly understood, and reports indicate that they may be more complex than lipolysis in adipose tissue. Electrical stimulation is used to induce acute contractile stimulation in isolated fibers [<xref rid="B90" ref-type="bibr">90</xref>]. Interestingly, LD and PAT associations are differentially modified in adipose tissue and skeletal muscle when chronic stimulation is applied, such as endurance training [<xref rid="B91" ref-type="bibr">91</xref>].</p><p>LDs, PLIN2, and PLIN5 are located in the subsarcolemmal region during rest. PLIN2 and PLIN5 are found in LDs and in the cytosol. Neither PLIN2 nor PLIN5 localization changes after contraction in soleus muscle, even when LD content is decreased after electrical stimulation [<xref rid="B92" ref-type="bibr">92</xref>]. As mentioned above, ATGL and CGI-58 are necessary for the activation of HSL in the regulation of lipolysis. In this context, both PLIN2 and HSL translocate to LDs after electrically stimulated acute contraction [<xref rid="B93" ref-type="bibr">93</xref>]. In fact, exercise rapidly triggers protein kinase A-dependent HSL activation in humans, promoting FA release [<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B94" ref-type="bibr">94</xref>]. ATGL-CGI-58 protein interaction increases and ATGL-PLIN2 decreases after electrical stimulation [<xref rid="B75" ref-type="bibr">75</xref>]. The same acute stimulation is capable of increasing mitochondrial PLIN5 content in rats [<xref rid="B76" ref-type="bibr">76</xref>]. However, chronic exercise does not change PLIN5 level in muscle biopsies obtained from patients subjected to training intervention [<xref rid="B84" ref-type="bibr">84</xref>]. PLIN4 mRNA, in turn, is decreased after exercise programs consisting of combined strength and endurance training for 12 weeks [<xref rid="B84" ref-type="bibr">84</xref>].</p></sec><sec id="sec5"><title>5. Findings on Insulin Resistance in Skeletal Muscle</title><sec id="sec5.1"><title>5.1. Obesity as a Main Cause of Insulin Resistance</title><p>Despite the great knowledge that has been generated in the recent years by studying the molecular mechanisms involved in the generation of IR as a result of obesity, several questions remain unresolved. Obesity is characterized by enhanced accumulation of FAs in adipose tissue, liver, and skeletal muscle, and HFD feeding is an accepted model for obesity and IR. Long-term HFD feeding produces an increase in LD content and PLIN5 expression in skeletal muscle [<xref rid="B95" ref-type="bibr">95</xref>]. As discussed above, one of the mechanisms involved in HFD-dependent IR is the presence of toxic lipid intermediates as a result of lipid management derangements.</p></sec><sec id="sec5.2"><title>5.2. Oxidative Stress</title><p>An intracellular pro-oxidative environment has been reported in skeletal muscle from obese and insulin-resistant individuals. We have shown that insulin-resistant mice show increased insulin-stimulated H<sub>2</sub>O<sub>2</sub> release, and a decreased reduced-to-oxidized glutathione ratio [<xref rid="B96" ref-type="bibr">96</xref>]. Some reports suggest that PLIN5 plays a protective role against oxidative burden in the heart, suppressing excess ROS production by sequestering FAs in TAGs [<xref rid="B97" ref-type="bibr">97</xref>], but there is no direct evidence in skeletal muscle showing that ROS are involved in the gene expression of PLINs.</p></sec><sec id="sec5.3"><title>5.3. Lipotoxicity</title><p>Lipotoxicity leads to the damage of organelles that are necessary for intracellular metabolic control, due to an excessive accumulation of lipid intermediates such as lipid-derived DAGs and ceramides [<xref rid="B41" ref-type="bibr">41</xref>]. As described before, it has been proposed that the generation and accumulation of these lipid intermediates alters insulin-stimulated glucose uptake [<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B49" ref-type="bibr">49</xref>&#x02013;<xref rid="B51" ref-type="bibr">51</xref>]. FA intermediates activate serine/threonine kinases that impair the ability of the insulin receptor to activate downstream targets, as IRS-1. This leads to decreased translocation of GLUT4 and therefore reduced glucose uptake into skeletal muscle cells [<xref rid="B98" ref-type="bibr">98</xref>&#x02013;<xref rid="B100" ref-type="bibr">100</xref>]. Skeletal muscle uses LDs as a protective mechanism against the accumulation of these lipid intermediates. As for the role of PLIN2 in lipotoxicity, it has been reported that PLIN2 knockdown prevents intramyocellular TAG storage, while PLIN2 overexpression augments myocellular fat storage and neutral TAG accumulation in LDs [<xref rid="B77" ref-type="bibr">77</xref>]. DAG levels are not increased in this model. Accordingly, PLIN2 overexpression reverts palmitate-induced impairments in insulin signaling [<xref rid="B77" ref-type="bibr">77</xref>]. Increased PLIN2 expression inhibits GLUT-mediated glucose uptake into skeletal cells apparently via the retention of SNARE fusion machinery proteins for vesicular fusion at the plasma membrane. This suggests that PLIN2 may play an important role in regulating skeletal insulin response [<xref rid="B101" ref-type="bibr">101</xref>]. In fact, PLIN2 is increased in skeletal muscle from rats with genetic-induced diabetes, which might be considered as a compensatory mechanism to deal with excessive lipid load (<xref ref-type="fig" rid="fig1">Figure 1(d)</xref>) [<xref rid="B74" ref-type="bibr">74</xref>]. Interestingly, skeletal muscle from patients with T2DM had lower PLIN2 gene expression compared to the skeletal muscle of obese control subjects, although a trend to increased protein levels was observed [<xref rid="B102" ref-type="bibr">102</xref>].</p><p>Studies from two separate groups report that overexpression of PLIN5 in skeletal muscle results in increased LD size and richness in TAGs but does not impair insulin sensitivity [<xref rid="B88" ref-type="bibr">88</xref>, <xref rid="B89" ref-type="bibr">89</xref>]. In fact, T2DM patients' muscle biopsies do not show significant differences in PLIN5 levels compared to matched control patients [<xref rid="B74" ref-type="bibr">74</xref>]. These findings may be explained by the reports that PLIN5 overexpression in skeletal muscle is capable of protecting the cells against lipotoxicity by increasing the amount of esterified lipid chains into LDs [<xref rid="B103" ref-type="bibr">103</xref>]. DAG accumulation is reduced in PLIN5 overexpressing myotubes treated with palmitate, which elevates ceramides and DAG content [<xref rid="B103" ref-type="bibr">103</xref>]. On the other hand, fasting is a physiological IR model, in which PLIN5 has been proposed to decrease lipotoxicity by promoting interaction of LDs with mitochondria. Fasting produces an increase in insulin resistance and mitochondrial dysfunction associated with higher presence of PLIN5 in LDs (<xref ref-type="fig" rid="fig1">Figure 1(d)</xref>). The authors hypothesized that this effect could be explained by an expanded capacity for inert lipid storage [<xref rid="B104" ref-type="bibr">104</xref>].</p></sec><sec id="sec5.4"><title>5.4. Autophagy</title><p>Autophagy is a cellular process that generates the degradation of damaged cytoplasmic organelles and proteins [<xref rid="B105" ref-type="bibr">105</xref>]. LDs contribute to the initiation of autophagy, promoting autophagosome biogenesis through phosphatidylcholine generation from TAG hydrolysis [<xref rid="B106" ref-type="bibr">106</xref>].</p><p>Mitochondrial function has been shown to be impaired in IR-related diseases. Maintaining autophagy flux is necessary to prevent accumulation of dysfunctional mitochondria and conserve the skeletal muscle mass [<xref rid="B105" ref-type="bibr">105</xref>]. Recently, it has been proposed that LDs are linked to the dynamic mitochondrial process. In skeletal muscle, the presence of damaged mitochondria generates oxidative stress and apoptosis, both of which can produce atrophy and muscular weakness [<xref rid="B107" ref-type="bibr">107</xref>]. Skeletal muscle from IR individuals has a higher degree of oxidative stress and toxic lipid intermediates accumulation, both conditions associated to mitochondrial damage [<xref rid="B108" ref-type="bibr">108</xref>]. Dynamin-related protein-1 (Drp-1) participates in mitochondrial fragmentation, which may result in mitochondrial dysfunction and IR [<xref rid="B109" ref-type="bibr">109</xref>]. Specifically, it was described that CGI-58 promotes mitochondrial fission through upregulation of Drp-1 expression producing mitochondrial fragmentation. Reports also showed that CGI-58 overexpression leads to significantly higher basal levels of both autophagy and mitophagy in the C2C12 myotube cell line [<xref rid="B110" ref-type="bibr">110</xref>]. Intracellular lipidic stores can be broken down through the process of autophagy, a catabolic pathway that ultimately delivers specific cargo to lysosomal degradation. It has been suggested that PAT- and LD-interacting proteins are part of the autophagy machinery, driving the process of LD recycling [<xref rid="B111" ref-type="bibr">111</xref>, <xref rid="B112" ref-type="bibr">112</xref>]. Elegant genetic and imaging approaches have shown that LDs are engulfed by autophagosomes and then associated with lysosomes for degradation [<xref rid="B113" ref-type="bibr">113</xref>]. Furthermore, this process is accompanied by degradation of PLIN2 and PLIN3 in the LDs, allowing for effective recruitment of the autophagic machinery and metabolism of the TAG contained within [<xref rid="B114" ref-type="bibr">114</xref>]. The LDs' role in autophagy in skeletal muscle is an open field of research.</p></sec><sec id="sec5.5"><title>5.5. Insulin Resistance Independent of Impaired Insulin Signaling</title><p>A great proportion of specialized literature suggest that IR in skeletal muscle is a result of impaired insulin signaling. Considering that GLUT4 appears to be responsible for most of both contraction- and insulin-stimulated glucose transport, any defect produced in GLUT4 subcellular trafficking could be responsible of glucose uptake impairment, which is the ultimate step in insulin action.</p><p>Upon contraction or insulin stimulation, GLUT4-containing vesicles translocate, dock, and fuse with the plasma membrane through the action of N-ethylmaleimide-sensitive factor attachment protein receptors, known as SNARE fusion machinery proteins [<xref rid="B115" ref-type="bibr">115</xref>, <xref rid="B116" ref-type="bibr">116</xref>]. In this regard, PLIN2 overexpression inhibits GLUT4-mediated glucose uptake, with the apparent mechanism being retaining SNARE proteins for vesicular fusion at the plasma membrane, suggesting that PLIN2 may play an important role in regulating glucose uptake [<xref rid="B101" ref-type="bibr">101</xref>]. Furthermore, SNARE proteins have been found in LDs and mitochondria in skeletal muscle [<xref rid="B117" ref-type="bibr">117</xref>], which suggests that other PLIN isoforms, as PLIN3 or PLIN5, might also be involved. GLUT4-vesicule fusion to plasma membrane is also dependent on Ca<sup>2+</sup> signaling [<xref rid="B118" ref-type="bibr">118</xref>, <xref rid="B119" ref-type="bibr">119</xref>], and therefore, disturbances in Ca<sup>2+</sup> homeostasis could be a factor involved in insulin resistance, independent of impaired insulin signaling.</p></sec></sec><sec id="sec6"><title>6. Conclusions</title><p>Until now, questions regarding the specific functions of different PLINs in skeletal muscle remain unanswered. The fact that two completely different physiological conditions, as IR and exercise, results in the accumulation of LDs in skeletal muscle continues to be a topic of debate. Could it be that different patterns of PATs in LDs causes this difference? Another possibility is that the intracellular distribution of the LDs differs in these two conditions, as their interactions with organelles such as mitochondria and lysosomes is becoming an apparent regulatory mechanism in LD dynamics. Despite the current uncertainties, it may be conceived that PLIN protein function in skeletal muscle is similar to that observed in adipose tissue: regulators and promoters of FA intake into LDs, and physical mediators that facilitate its further metabolization in mitochondria.</p><p>Throughout this review, we have depict the different and multiple processes involved in lipid metabolism in skeletal muscle. The myriad of stimuli that act on skeletal muscle (such as insulin, contraction, and adrenergic stimulation) and the tone of activation (whether it is acute or chronic); all of them can impinge on lipid metabolic pathways. In consequence, a detailed study on all of these variables is necessary in order to more precisely conclude the role of LDs in skeletal muscle in both healthy and disease states.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank Payton Ottum for the critical reading of the manuscript and C&#x000e9;sar V&#x000e1;squez-Trincado for his aid in the figure construction. This work was supported by the National Fund for Scientific and Technological Development (Fondecyt, 1151293).</p></ack><sec><title>Conflicts of Interest</title><p>The authors declare that they have no conflicts of interest.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arroyo-Johnson</surname><given-names>C.</given-names></name><name><surname>Mincey</surname><given-names>K. D.</given-names></name></person-group><article-title>Obesity epidemiology worldwide</article-title><source><italic>Gastroenterology Clinics of North America</italic></source><year>2016</year><volume>45</volume><issue>4</issue><fpage>571</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1016/j.gtc.2016.07.012</pub-id><pub-id pub-id-type="other">2-s2.0-84995470097</pub-id><pub-id pub-id-type="other">84995470097</pub-id><?supplied-pmid 27837773?><pub-id pub-id-type="pmid">27837773</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guariguata</surname><given-names>L.</given-names></name><name><surname>Whiting</surname><given-names>D. R.</given-names></name><name><surname>Hambleton</surname><given-names>I.</given-names></name><name><surname>Beagley</surname><given-names>J.</given-names></name><name><surname>Linnenkamp</surname><given-names>U.</given-names></name><name><surname>Shaw</surname><given-names>J. E.</given-names></name></person-group><article-title>Global estimates of diabetes prevalence for 2013 and projections for 2035</article-title><source><italic>Diabetes Research and Clinical Practice</italic></source><year>2014</year><volume>103</volume><issue>2</issue><fpage>137</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2013.11.002</pub-id><pub-id pub-id-type="other">2-s2.0-84895832615</pub-id><pub-id pub-id-type="other">84895832615</pub-id><?supplied-pmid 24630390?><pub-id pub-id-type="pmid">24630390</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jallut</surname><given-names>D.</given-names></name><name><surname>Golay</surname><given-names>A.</given-names></name><name><surname>Munger</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism</article-title><source><italic>Metabolism</italic></source><year>1990</year><volume>39</volume><issue>10</issue><fpage>1068</fpage><lpage>1075</lpage><pub-id pub-id-type="doi">10.1016/0026-0495(90)90168-C</pub-id><pub-id pub-id-type="other">2-s2.0-0025059405</pub-id><pub-id pub-id-type="other">0025059405</pub-id><?supplied-pmid 2215253?><pub-id pub-id-type="pmid">2215253</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guh</surname><given-names>D. P.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Bansback</surname><given-names>N.</given-names></name><name><surname>Amarsi</surname><given-names>Z.</given-names></name><name><surname>Birmingham</surname><given-names>C. L.</given-names></name><name><surname>Anis</surname><given-names>A. H.</given-names></name></person-group><article-title>The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis</article-title><source><italic>BMC Public Health</italic></source><year>2009</year><volume>9</volume><fpage>p. 88</fpage><pub-id pub-id-type="doi">10.1186/1471-2458-9-88</pub-id><pub-id pub-id-type="other">2-s2.0-64649083354</pub-id><?supplied-pmid 19320986?><pub-id pub-id-type="pmid">19320986</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reaven</surname><given-names>G. M.</given-names></name><name><surname>Hollenbeck</surname><given-names>C.</given-names></name><name><surname>Jeng</surname><given-names>C. Y.</given-names></name><name><surname>Wu</surname><given-names>M. S.</given-names></name><name><surname>Chen</surname><given-names>Y. D.</given-names></name></person-group><article-title>Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM</article-title><source><italic>Diabetes</italic></source><year>1988</year><volume>37</volume><issue>8</issue><fpage>1020</fpage><lpage>1024</lpage><pub-id pub-id-type="doi">10.2337/diab.37.8.1020</pub-id><pub-id pub-id-type="other">0024244339</pub-id><?supplied-pmid 3292322?><pub-id pub-id-type="pmid">3292322</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golay</surname><given-names>A.</given-names></name><name><surname>Swislocki</surname><given-names>A. L.</given-names></name><name><surname>Chen</surname><given-names>Y. D.</given-names></name><name><surname>Reaven</surname><given-names>G. M.</given-names></name></person-group><article-title>Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals</article-title><source><italic>Metabolism</italic></source><year>1987</year><volume>36</volume><issue>7</issue><fpage>692</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1016/0026-0495(87)90156-9</pub-id><pub-id pub-id-type="other">2-s2.0-0023189066</pub-id><pub-id pub-id-type="other">0023189066</pub-id><?supplied-pmid 3298937?><pub-id pub-id-type="pmid">3298937</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberti</surname><given-names>K. G.</given-names></name><name><surname>Zimmet</surname><given-names>P. Z.</given-names></name></person-group><article-title>Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation</article-title><source><italic>Diabetic Medicine</italic></source><year>1998</year><volume>15</volume><issue>7</issue><fpage>539</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9136(199807)15:7&#x0003c;539::AID-DIA668&#x0003e;3.0.CO;2-S</pub-id><pub-id pub-id-type="other">0031851293</pub-id><?supplied-pmid 9686693?><pub-id pub-id-type="pmid">9686693</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cersosimo</surname><given-names>E.</given-names></name><name><surname>Triplitt</surname><given-names>C.</given-names></name><name><surname>Mandarino</surname><given-names>L. J.</given-names></name><name><surname>RA</surname><given-names>D. F.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>De Groot</surname><given-names>L. J.</given-names></name><name><surname>Chrousos</surname><given-names>G.</given-names></name><name><surname>Dungan</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Pathogenesis of type 2 diabetes mellitus</article-title><source><italic>Endotext</italic></source><year>2000</year><publisher-loc>South Dartmouth (MA)</publisher-loc><publisher-name>MDText.com, Inc.</publisher-name><?supplied-pmid 25905339?></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeFronzo</surname><given-names>R. A.</given-names></name><name><surname>Gunnarsson</surname><given-names>R.</given-names></name><name><surname>Bjorkman</surname><given-names>O.</given-names></name><name><surname>Olsson</surname><given-names>M.</given-names></name><name><surname>Wahren</surname><given-names>J.</given-names></name></person-group><article-title>Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus</article-title><source><italic>The Journal of Clinical Investigation</italic></source><year>1985</year><volume>76</volume><issue>1</issue><fpage>149</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1172/JCI111938</pub-id><pub-id pub-id-type="other">0021994683</pub-id><?supplied-pmid 3894418?><pub-id pub-id-type="pmid">3894418</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeFronzo</surname><given-names>R. A.</given-names></name><name><surname>Jacot</surname><given-names>E.</given-names></name><name><surname>Jequier</surname><given-names>E.</given-names></name><name><surname>Maeder</surname><given-names>E.</given-names></name><name><surname>Wahren</surname><given-names>J.</given-names></name><name><surname>Felber</surname><given-names>J. P.</given-names></name></person-group><article-title>The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization</article-title><source><italic>Diabetes</italic></source><year>1981</year><volume>30</volume><issue>12</issue><fpage>1000</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.2337/diab.30.12.1000</pub-id><pub-id pub-id-type="other">0019762341</pub-id><?supplied-pmid 7030826?><pub-id pub-id-type="pmid">7030826</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrannini</surname><given-names>E.</given-names></name><name><surname>Bjorkman</surname><given-names>O.</given-names></name><name><surname>Reichard</surname><given-names>G. A.</given-names><suffix>Jr</suffix></name></person-group><person-group person-group-type="author"><name><surname>Pilo</surname><given-names>A.</given-names></name><name><surname>Olsson</surname><given-names>M.</given-names></name><name><surname>Wahren</surname><given-names>J.</given-names></name><name><surname>DeFronzo</surname><given-names>R. A.</given-names></name></person-group><article-title>The disposal of an oral glucose load in healthy subjects. A quantitative study</article-title><source><italic>Diabetes</italic></source><year>1985</year><volume>34</volume><issue>6</issue><fpage>580</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.2337/diab.34.6.580</pub-id><pub-id pub-id-type="other">0021882037</pub-id><?supplied-pmid 3891471?><pub-id pub-id-type="pmid">3891471</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>D. E.</given-names></name><name><surname>Strube</surname><given-names>M.</given-names></name><name><surname>Mueckler</surname><given-names>M.</given-names></name></person-group><article-title>Molecular cloning and characterization of an insulin-regulatable glucose transporter</article-title><source><italic>Nature</italic></source><year>1989</year><volume>338</volume><issue>6210</issue><fpage>83</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1038/338083a0</pub-id><pub-id pub-id-type="other">0024592462</pub-id><?supplied-pmid 2645527?><pub-id pub-id-type="pmid">2645527</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birnbaum</surname><given-names>M. J.</given-names></name></person-group><article-title>Identification of a novel gene encoding an insulin-responsive glucose transporter protein</article-title><source><italic>Cell</italic></source><year>1989</year><volume>57</volume><issue>2</issue><fpage>305</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(89)90968-9</pub-id><pub-id pub-id-type="other">2-s2.0-0024512585</pub-id><pub-id pub-id-type="other">0024512585</pub-id><?supplied-pmid 2649253?><pub-id pub-id-type="pmid">2649253</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>S.</given-names></name><name><surname>Czech</surname><given-names>M. P.</given-names></name></person-group><article-title>The GLUT4 glucose transporter</article-title><source><italic>Cell Metabolism</italic></source><year>2007</year><volume>5</volume><issue>4</issue><fpage>237</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2007.03.006</pub-id><pub-id pub-id-type="other">2-s2.0-33947596679</pub-id><pub-id pub-id-type="other">33947596679</pub-id><?supplied-pmid 17403369?><pub-id pub-id-type="pmid">17403369</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thong</surname><given-names>F. S.</given-names></name><name><surname>Dugani</surname><given-names>C. B.</given-names></name><name><surname>Klip</surname><given-names>A.</given-names></name></person-group><article-title>Turning signals on and off: GLUT4 traffic in the insulin-signaling highway</article-title><source><italic>Physiology (Bethesda)</italic></source><year>2005</year><volume>20</volume><issue>4</issue><fpage>271</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1152/physiol.00017.2005</pub-id><pub-id pub-id-type="pmid">16024515</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraze</surname><given-names>E.</given-names></name><name><surname>Donner</surname><given-names>C. C.</given-names></name><name><surname>Swislocki</surname><given-names>A. L.</given-names></name><name><surname>Chiou</surname><given-names>Y. A.</given-names></name><name><surname>Chen</surname><given-names>Y. D.</given-names></name><name><surname>Reaven</surname><given-names>G. M.</given-names></name></person-group><article-title>Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance</article-title><source><italic>The Journal of Clinical Endocrinology and Metabolism</italic></source><year>1985</year><volume>61</volume><issue>5</issue><fpage>807</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1210/jcem-61-5-807</pub-id><pub-id pub-id-type="other">2-s2.0-0022388940</pub-id><pub-id pub-id-type="other">0022388940</pub-id><?supplied-pmid 3900120?><pub-id pub-id-type="pmid">3900120</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holland</surname><given-names>W. L.</given-names></name><name><surname>Brozinick</surname><given-names>J. T.</given-names></name><name><surname>Wang</surname><given-names>L. P.</given-names></name><etal/></person-group><article-title>Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance</article-title><source><italic>Cell Metabolism</italic></source><year>2007</year><volume>5</volume><issue>3</issue><fpage>167</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2007.01.002</pub-id><pub-id pub-id-type="other">2-s2.0-33847332202</pub-id><?supplied-pmid 17339025?><pub-id pub-id-type="pmid">17339025</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krssak</surname><given-names>M.</given-names></name><name><surname>Falk Petersen</surname><given-names>K.</given-names></name><name><surname>Dresner</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study</article-title><source><italic>Diabetologia</italic></source><year>1999</year><volume>42</volume><issue>1</issue><fpage>113</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1007/s001250051123</pub-id><pub-id pub-id-type="other">2-s2.0-0032934826</pub-id><pub-id pub-id-type="other">0032934826</pub-id><?supplied-pmid 10027589?><pub-id pub-id-type="pmid">10027589</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Cline</surname><given-names>G. W.</given-names></name><etal/></person-group><article-title>Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2002</year><volume>277</volume><issue>52</issue><fpage>50230</fpage><lpage>50236</lpage><pub-id pub-id-type="doi">10.1074/jbc.M200958200</pub-id><pub-id pub-id-type="other">2-s2.0-0037184925</pub-id><pub-id pub-id-type="other">0037184925</pub-id><?supplied-pmid 12006582?><pub-id pub-id-type="pmid">12006582</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itani</surname><given-names>S. I.</given-names></name><name><surname>Ruderman</surname><given-names>N. B.</given-names></name><name><surname>Schmieder</surname><given-names>F.</given-names></name><name><surname>Boden</surname><given-names>G.</given-names></name></person-group><article-title>Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha</article-title><source><italic>Diabetes</italic></source><year>2002</year><volume>51</volume><issue>7</issue><fpage>2005</fpage><lpage>2011</lpage><pub-id pub-id-type="doi">10.2337/diabetes.51.7.2005</pub-id><pub-id pub-id-type="other">0036300538</pub-id><?supplied-pmid 12086926?><pub-id pub-id-type="pmid">12086926</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hulver</surname><given-names>M. W.</given-names></name><name><surname>Berggren</surname><given-names>J. R.</given-names></name><name><surname>Cortright</surname><given-names>R. N.</given-names></name><etal/></person-group><article-title>Skeletal muscle lipid metabolism with obesity</article-title><source><italic>American Journal of Physiology. Endocrinology and Metabolism</italic></source><year>2003</year><volume>284</volume><issue>4</issue><fpage>E741</fpage><lpage>E747</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00514.2002</pub-id><pub-id pub-id-type="other">0037376854</pub-id><?supplied-pmid 12626325?><pub-id pub-id-type="pmid">12626325</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sylow</surname><given-names>L.</given-names></name><name><surname>Kleinert</surname><given-names>M.</given-names></name><name><surname>Richter</surname><given-names>E. A.</given-names></name><name><surname>Jensen</surname><given-names>T. E.</given-names></name></person-group><article-title>Exercise-stimulated glucose uptake - regulation and implications for glycaemic control</article-title><source><italic>Nature Reviews. Endocrinology</italic></source><year>2017</year><volume>13</volume><issue>3</issue><fpage>133</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1038/nrendo.2016.162</pub-id><pub-id pub-id-type="other">2-s2.0-84990942554</pub-id><pub-id pub-id-type="other">84990942554</pub-id><?supplied-pmid 27739515?><pub-id pub-id-type="pmid">27739515</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eaton</surname><given-names>S.</given-names></name></person-group><article-title>Control of mitochondrial beta-oxidation flux</article-title><source><italic>Progress in Lipid Research</italic></source><year>2002</year><volume>41</volume><issue>3</issue><fpage>197</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1016/S0163-7827(01)00024-8</pub-id><pub-id pub-id-type="other">2-s2.0-0036154857</pub-id><pub-id pub-id-type="other">0036154857</pub-id><?supplied-pmid 11814524?><pub-id pub-id-type="pmid">11814524</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>S. J.</given-names></name><name><surname>Dyck</surname><given-names>D. J.</given-names></name><name><surname>Bonen</surname><given-names>A.</given-names></name><name><surname>Spriet</surname><given-names>L. L.</given-names></name></person-group><article-title>Effects of epinephrine on lipid metabolism in resting skeletal muscle</article-title><source><italic>The American Journal of Physiology</italic></source><year>1998</year><volume>275</volume><issue>2 Part 1</issue><fpage>E300</fpage><lpage>E309</lpage><?supplied-pmid 9688633?><pub-id pub-id-type="pmid">9688633</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyck</surname><given-names>D. J.</given-names></name><name><surname>Bonen</surname><given-names>A.</given-names></name></person-group><article-title>Muscle contraction increases palmitate esterification and oxidation and triacylglycerol oxidation</article-title><source><italic>The American Journal of Physiology</italic></source><year>1998</year><volume>275</volume><issue>5 Part 1</issue><fpage>E888</fpage><lpage>E896</lpage><?supplied-pmid 9815010?><pub-id pub-id-type="pmid">9815010</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dube</surname><given-names>J. J.</given-names></name><name><surname>Coen</surname><given-names>P. M.</given-names></name><name><surname>DiStefano</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Effects of acute lipid overload on skeletal muscle insulin resistance, metabolic flexibility, and mitochondrial performance</article-title><source><italic>American Journal of Physiology. Endocrinology and Metabolism</italic></source><year>2014</year><volume>307</volume><issue>12</issue><fpage>E1117</fpage><lpage>E1124</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00257.2014</pub-id><pub-id pub-id-type="other">2-s2.0-84918798518</pub-id><?supplied-pmid 25352435?><pub-id pub-id-type="pmid">25352435</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ukropcova</surname><given-names>B.</given-names></name><name><surname>McNeil</surname><given-names>M.</given-names></name><name><surname>Sereda</surname><given-names>O.</given-names></name><etal/></person-group><article-title>Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor</article-title><source><italic>The Journal of Clinical Investigation</italic></source><year>2005</year><volume>115</volume><issue>7</issue><fpage>1934</fpage><lpage>1941</lpage><pub-id pub-id-type="doi">10.1172/JCI24332</pub-id><pub-id pub-id-type="other">2-s2.0-22144472218</pub-id><pub-id pub-id-type="other">22144472218</pub-id><?supplied-pmid 16007256?><pub-id pub-id-type="pmid">16007256</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFarlan</surname><given-names>J. T.</given-names></name><name><surname>Yoshida</surname><given-names>Y.</given-names></name><name><surname>Jain</surname><given-names>S. S.</given-names></name><etal/></person-group><article-title>In vivo, fatty acid translocase (CD36) critically regulates skeletal muscle fuel selection, exercise performance, and training-induced adaptation of fatty acid oxidation</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2012</year><volume>287</volume><issue>28</issue><fpage>23502</fpage><lpage>23516</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.315358</pub-id><pub-id pub-id-type="other">2-s2.0-84863617800</pub-id><pub-id pub-id-type="other">84863617800</pub-id><?supplied-pmid 22584574?><pub-id pub-id-type="pmid">22584574</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotamisligil</surname><given-names>G. S.</given-names></name><name><surname>Bernlohr</surname><given-names>D. A.</given-names></name></person-group><article-title>Metabolic functions of FABPs&#x02014;mechanisms and therapeutic implications</article-title><source><italic>Nature Reviews. Endocrinology</italic></source><year>2015</year><volume>11</volume><issue>10</issue><fpage>592</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1038/nrendo.2015.122</pub-id><pub-id pub-id-type="other">2-s2.0-84941876397</pub-id><pub-id pub-id-type="other">84941876397</pub-id><?supplied-pmid 26260145?><pub-id pub-id-type="pmid">26260145</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazantzis</surname><given-names>M.</given-names></name><name><surname>Stahl</surname><given-names>A.</given-names></name></person-group><article-title>Fatty acid transport proteins, implications in physiology and disease</article-title><source><italic>Biochimica et Biophysica Acta</italic></source><year>2012</year><volume>1821</volume><issue>5</issue><fpage>852</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2011.09.010</pub-id><pub-id pub-id-type="other">2-s2.0-84859157750</pub-id><?supplied-pmid 21979150?><pub-id pub-id-type="pmid">21979150</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luiken</surname><given-names>J. J.</given-names></name><name><surname>Koonen</surname><given-names>D. P.</given-names></name><name><surname>Willems</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36</article-title><source><italic>Diabetes</italic></source><year>2002</year><volume>51</volume><issue>10</issue><fpage>3113</fpage><lpage>3119</lpage><pub-id pub-id-type="doi">10.2337/diabetes.51.10.3113</pub-id><pub-id pub-id-type="other">0036787393</pub-id><?supplied-pmid 12351456?><pub-id pub-id-type="pmid">12351456</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>S. S.</given-names></name><name><surname>Luiken</surname><given-names>J. J.</given-names></name><name><surname>Snook</surname><given-names>L. A.</given-names></name><etal/></person-group><article-title>Fatty acid transport and transporters in muscle are critically regulated by Akt2</article-title><source><italic>FEBS Letters</italic></source><year>2015</year><volume>589</volume><issue>19 Part B</issue><fpage>2769</fpage><lpage>2775</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2015.08.010</pub-id><pub-id pub-id-type="other">2-s2.0-84941424423</pub-id><?supplied-pmid 26296318?><pub-id pub-id-type="pmid">26296318</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>B. K.</given-names></name><name><surname>Bonen</surname><given-names>A.</given-names></name><name><surname>Holloway</surname><given-names>G. P.</given-names></name></person-group><article-title>A dual mechanism of action for skeletal muscle FAT/CD36 during exercise</article-title><source><italic>Exercise and Sport Sciences Reviews</italic></source><year>2012</year><volume>40</volume><issue>4</issue><fpage>211</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1097/JES.0b013e31825eb263</pub-id><pub-id pub-id-type="other">2-s2.0-84866941177</pub-id><pub-id pub-id-type="other">84866941177</pub-id><?supplied-pmid 22653277?><pub-id pub-id-type="pmid">22653277</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeppesen</surname><given-names>J.</given-names></name><name><surname>Albers</surname><given-names>P. H.</given-names></name><name><surname>Rose</surname><given-names>A. J.</given-names></name><etal/></person-group><article-title>Contraction-induced skeletal muscle FAT/CD36 trafficking and FA uptake is AMPK independent</article-title><source><italic>Journal of Lipid Research</italic></source><year>2011</year><volume>52</volume><issue>4</issue><fpage>699</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.1194/jlr.M007138</pub-id><pub-id pub-id-type="other">2-s2.0-79953297052</pub-id><pub-id pub-id-type="other">79953297052</pub-id><?supplied-pmid 21297178?><pub-id pub-id-type="pmid">21297178</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonen</surname><given-names>A.</given-names></name><name><surname>Jain</surname><given-names>S. S.</given-names></name><name><surname>Snook</surname><given-names>L. A.</given-names></name><etal/></person-group><article-title>Extremely rapid increase in fatty acid transport and intramyocellular lipid accumulation but markedly delayed insulin resistance after high fat feeding in rats</article-title><source><italic>Diabetologia</italic></source><year>2015</year><volume>58</volume><issue>10</issue><fpage>2381</fpage><lpage>2391</lpage><pub-id pub-id-type="doi">10.1007/s00125-015-3691-8</pub-id><pub-id pub-id-type="other">2-s2.0-84942192380</pub-id><pub-id pub-id-type="other">84942192380</pub-id><?supplied-pmid 26197708?><pub-id pub-id-type="pmid">26197708</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luiken</surname><given-names>J. J.</given-names></name><name><surname>Miskovic</surname><given-names>D.</given-names></name><name><surname>Arumugam</surname><given-names>Y.</given-names></name><name><surname>Glatz</surname><given-names>J. F.</given-names></name><name><surname>Bonen</surname><given-names>A.</given-names></name></person-group><article-title>Skeletal muscle fatty acid transport and transporters</article-title><source><italic>International Journal of Sport Nutrition and Exercise Metabolism</italic></source><year>2001</year><volume>11</volume><issue>s1</issue><fpage>S92</fpage><lpage>S96</lpage><?supplied-pmid 11915935?><pub-id pub-id-type="pmid">11915935</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>Z.</given-names></name><name><surname>Pei</surname><given-names>Z.</given-names></name><name><surname>Maiguel</surname><given-names>D.</given-names></name><name><surname>Toomer</surname><given-names>C. J.</given-names></name><name><surname>Watkins</surname><given-names>P. A.</given-names></name></person-group><article-title>The fatty acid transport protein (FATP) family: very long chain acyl-CoA synthetases or solute carriers?</article-title><source><italic>Journal of Molecular Neuroscience</italic></source><year>2007</year><volume>33</volume><issue>1</issue><fpage>25</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1007/s12031-007-0038-z</pub-id><pub-id pub-id-type="other">2-s2.0-35348860747</pub-id><pub-id pub-id-type="other">35348860747</pub-id><?supplied-pmid 17901542?><pub-id pub-id-type="pmid">17901542</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefanyk</surname><given-names>L. E.</given-names></name><name><surname>Bonen</surname><given-names>A.</given-names></name><name><surname>Dyck</surname><given-names>D. J.</given-names></name></person-group><article-title>Insulin and contraction-induced movement of fatty acid transport proteins to skeletal muscle transverse-tubules is distinctly different than to the sarcolemma</article-title><source><italic>Metabolism</italic></source><year>2012</year><volume>61</volume><issue>11</issue><fpage>1518</fpage><lpage>1522</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2012.04.002</pub-id><pub-id pub-id-type="other">2-s2.0-84867858900</pub-id><pub-id pub-id-type="other">84867858900</pub-id><?supplied-pmid 22560054?><pub-id pub-id-type="pmid">22560054</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holloway</surname><given-names>G. P.</given-names></name><name><surname>Chou</surname><given-names>C. J.</given-names></name><name><surname>Lally</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Increasing skeletal muscle fatty acid transport protein 1 (FATP1) targets fatty acids to oxidation and does not predispose mice to diet-induced insulin resistance</article-title><source><italic>Diabetologia</italic></source><year>2011</year><volume>54</volume><issue>6</issue><fpage>1457</fpage><lpage>1467</lpage><pub-id pub-id-type="doi">10.1007/s00125-011-2114-8</pub-id><pub-id pub-id-type="other">2-s2.0-80052538942</pub-id><pub-id pub-id-type="other">80052538942</pub-id><?supplied-pmid 21442160?><pub-id pub-id-type="pmid">21442160</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanaley</surname><given-names>J. A.</given-names></name><name><surname>Shadid</surname><given-names>S.</given-names></name><name><surname>Sheehan</surname><given-names>M. T.</given-names></name><name><surname>Guo</surname><given-names>Z.</given-names></name><name><surname>Jensen</surname><given-names>M. D.</given-names></name></person-group><article-title>Relationship between plasma free fatty acid, intramyocellular triglycerides and long-chain acylcarnitines in resting humans</article-title><source><italic>The Journal of Physiology</italic></source><year>2009</year><volume>587</volume><issue>Part 24</issue><fpage>5939</fpage><lpage>5950</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2009.180695</pub-id><pub-id pub-id-type="other">2-s2.0-72549084334</pub-id><?supplied-pmid 19858228?><pub-id pub-id-type="pmid">19858228</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Br&#x000f8;ns</surname><given-names>C.</given-names></name><name><surname>Grunnet</surname><given-names>L. G.</given-names></name></person-group><article-title>MECHANISMS IN ENDOCRINOLOGY: skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander?</article-title><source><italic>European Journal of Endocrinology</italic></source><year>2017</year><volume>176</volume><issue>2</issue><fpage>R67</fpage><lpage>R78</lpage><pub-id pub-id-type="doi">10.1530/EJE-16-0488</pub-id><?supplied-pmid 27913612?><pub-id pub-id-type="pmid">27913612</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>S.</given-names></name><name><surname>Machann</surname><given-names>J.</given-names></name><name><surname>Rett</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects</article-title><source><italic>Diabetes</italic></source><year>1999</year><volume>48</volume><issue>5</issue><fpage>1113</fpage><lpage>1119</lpage><pub-id pub-id-type="doi">10.2337/diabetes.48.5.1113</pub-id><pub-id pub-id-type="other">2-s2.0-0032960890</pub-id><pub-id pub-id-type="other">0032960890</pub-id><?supplied-pmid 10331418?><pub-id pub-id-type="pmid">10331418</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brioche</surname><given-names>T.</given-names></name><name><surname>Pagano</surname><given-names>A. F.</given-names></name><name><surname>Py</surname><given-names>G.</given-names></name><name><surname>Chopard</surname><given-names>A.</given-names></name></person-group><article-title>Muscle wasting and aging: experimental models, fatty infiltrations, and prevention</article-title><source><italic>Molecular Aspects of Medicine</italic></source><year>2016</year><volume>50</volume><fpage>56</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.mam.2016.04.006</pub-id><pub-id pub-id-type="other">2-s2.0-84964578117</pub-id><pub-id pub-id-type="other">84964578117</pub-id><?supplied-pmid 27106402?><pub-id pub-id-type="pmid">27106402</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosma</surname><given-names>M.</given-names></name></person-group><article-title>Lipid droplet dynamics in skeletal muscle</article-title><source><italic>Experimental Cell Research</italic></source><year>2016</year><volume>340</volume><issue>2</issue><fpage>180</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2015.10.023</pub-id><pub-id pub-id-type="other">2-s2.0-84957935221</pub-id><pub-id pub-id-type="other">84957935221</pub-id><?supplied-pmid 26515552?><pub-id pub-id-type="pmid">26515552</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>N.</given-names></name><name><surname>Patel</surname><given-names>N.</given-names></name><name><surname>Jiang</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Ceramide-activated protein phosphatase involvement in insulin resistance via Akt, serine/arginine-rich protein 40, and ribonucleic acid splicing in L6 skeletal muscle cells</article-title><source><italic>Endocrinology</italic></source><year>2007</year><volume>148</volume><issue>3</issue><fpage>1359</fpage><lpage>1366</lpage><pub-id pub-id-type="doi">10.1210/en.2006-0750</pub-id><pub-id pub-id-type="other">2-s2.0-33847036385</pub-id><pub-id pub-id-type="other">33847036385</pub-id><?supplied-pmid 17158207?><pub-id pub-id-type="pmid">17158207</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoeg</surname><given-names>L.</given-names></name><name><surname>Roepstorff</surname><given-names>C.</given-names></name><name><surname>Thiele</surname><given-names>M.</given-names></name><name><surname>Richter</surname><given-names>E. A.</given-names></name><name><surname>Wojtaszewski</surname><given-names>J. F.</given-names></name><name><surname>Kiens</surname><given-names>B.</given-names></name></person-group><article-title>Higher intramuscular triacylglycerol in women does not impair insulin sensitivity and proximal insulin signaling</article-title><source><italic>Journal of Applied Physiology (Bethesda, Md.: 1985)</italic></source><year>2009</year><volume>107</volume><issue>3</issue><fpage>824</fpage><lpage>831</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.91382.2008</pub-id><pub-id pub-id-type="other">2-s2.0-69749085980</pub-id><?supplied-pmid 19574502?><pub-id pub-id-type="pmid">19574502</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Loon</surname><given-names>L. J.</given-names></name><name><surname>Koopman</surname><given-names>R.</given-names></name><name><surname>Manders</surname><given-names>R.</given-names></name><name><surname>van der Weegen</surname><given-names>W.</given-names></name><name><surname>van Kranenburg</surname><given-names>G. P.</given-names></name><name><surname>Keizer</surname><given-names>H. A.</given-names></name></person-group><article-title>Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes</article-title><source><italic>American Journal of Physiology. Endocrinology and Metabolism</italic></source><year>2004</year><volume>287</volume><issue>3</issue><fpage>E558</fpage><lpage>E565</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00464.2003</pub-id><pub-id pub-id-type="other">2-s2.0-4143060180</pub-id><?supplied-pmid 15165998?><pub-id pub-id-type="pmid">15165998</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dube</surname><given-names>J. J.</given-names></name><name><surname>Amati</surname><given-names>F.</given-names></name><name><surname>Stefanovic-Racic</surname><given-names>M.</given-names></name><name><surname>Toledo</surname><given-names>F. G.</given-names></name><name><surname>Sauers</surname><given-names>S. E.</given-names></name><name><surname>Goodpaster</surname><given-names>B. H.</given-names></name></person-group><article-title>Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete&#x02019;s paradox revisited</article-title><source><italic>American Journal of Physiology. Endocrinology and Metabolism</italic></source><year>2008</year><volume>294</volume><issue>5</issue><fpage>E882</fpage><lpage>E888</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00769.2007</pub-id><pub-id pub-id-type="other">2-s2.0-45549084515</pub-id><?supplied-pmid 18319352?><pub-id pub-id-type="pmid">18319352</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraegen</surname><given-names>E. W.</given-names></name><name><surname>Saha</surname><given-names>A. K.</given-names></name><name><surname>Preston</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats</article-title><source><italic>American Journal of Physiology. Endocrinology and Metabolism</italic></source><year>2006</year><volume>290</volume><issue>3</issue><fpage>E471</fpage><lpage>E479</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00316.2005</pub-id><pub-id pub-id-type="other">2-s2.0-33645092172</pub-id><?supplied-pmid 16234268?><pub-id pub-id-type="pmid">16234268</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>M.</given-names></name><name><surname>Kaddai</surname><given-names>V.</given-names></name><name><surname>Ching</surname><given-names>J.</given-names></name><etal/></person-group><article-title>A role for ceramides, but not sphingomyelins, as antagonists of insulin signaling and mitochondrial metabolism in C2C12 myotubes</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2016</year><volume>291</volume><issue>46</issue><fpage>23978</fpage><lpage>23988</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.737684</pub-id><pub-id pub-id-type="other">2-s2.0-84994491935</pub-id><pub-id pub-id-type="other">84994491935</pub-id><?supplied-pmid 27703011?><pub-id pub-id-type="pmid">27703011</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chavez</surname><given-names>J. A.</given-names></name><name><surname>Summers</surname><given-names>S. A.</given-names></name></person-group><article-title>Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes</article-title><source><italic>Archives of Biochemistry and Biophysics</italic></source><year>2003</year><volume>419</volume><issue>2</issue><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2003.08.020</pub-id><pub-id pub-id-type="other">2-s2.0-0142164965</pub-id><pub-id pub-id-type="other">0142164965</pub-id><?supplied-pmid 14592453?><pub-id pub-id-type="pmid">14592453</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amati</surname><given-names>F.</given-names></name><name><surname>Dube</surname><given-names>J. J.</given-names></name><name><surname>Alvarez-Carnero</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?</article-title><source><italic>Diabetes</italic></source><year>2011</year><volume>60</volume><issue>10</issue><fpage>2588</fpage><lpage>2597</lpage><pub-id pub-id-type="doi">10.2337/db10-1221</pub-id><pub-id pub-id-type="other">2-s2.0-80053403320</pub-id><pub-id pub-id-type="other">80053403320</pub-id><?supplied-pmid 21873552?><pub-id pub-id-type="pmid">21873552</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zechner</surname><given-names>R.</given-names></name><name><surname>Kienesberger</surname><given-names>P. C.</given-names></name><name><surname>Haemmerle</surname><given-names>G.</given-names></name><name><surname>Zimmermann</surname><given-names>R.</given-names></name><name><surname>Lass</surname><given-names>A.</given-names></name></person-group><article-title>Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores</article-title><source><italic>Journal of Lipid Research</italic></source><year>2009</year><volume>50</volume><issue>1</issue><fpage>3</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1194/jlr.R800031-JLR200</pub-id><pub-id pub-id-type="other">2-s2.0-63449127032</pub-id><?supplied-pmid 18952573?><pub-id pub-id-type="pmid">18952573</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meex</surname><given-names>R. C.</given-names></name><name><surname>Hoy</surname><given-names>A. J.</given-names></name><name><surname>Mason</surname><given-names>R. M.</given-names></name><etal/></person-group><article-title>ATGL-mediated triglyceride turnover and the regulation of mitochondrial capacity in skeletal muscle</article-title><source><italic>American Journal of Physiology. Endocrinology and Metabolism</italic></source><year>2015</year><volume>308</volume><issue>11</issue><fpage>E960</fpage><lpage>E970</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00598.2014</pub-id><pub-id pub-id-type="other">2-s2.0-84930832958</pub-id><pub-id pub-id-type="other">84930832958</pub-id><?supplied-pmid 25852007?><pub-id pub-id-type="pmid">25852007</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>D.</given-names></name><name><surname>Ghosh</surname><given-names>M.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Chakrabarti</surname><given-names>P.</given-names></name></person-group><article-title>PPAR&#x003b1;-ATGL pathway improves muscle mitochondrial metabolism: implication in aging</article-title><source><italic>The FASEB Journal</italic></source><year>2016</year><volume>30</volume><issue>11</issue><fpage>3822</fpage><lpage>3834</lpage><pub-id pub-id-type="doi">10.1096/fj.201600571RR</pub-id><pub-id pub-id-type="other">2-s2.0-84996486503</pub-id><pub-id pub-id-type="other">84996486503</pub-id><?supplied-pmid 27485820?><pub-id pub-id-type="pmid">27485820</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turnbull</surname><given-names>P. C.</given-names></name><name><surname>Longo</surname><given-names>A. B.</given-names></name><name><surname>Ramos</surname><given-names>S. V.</given-names></name><name><surname>Roy</surname><given-names>B. D.</given-names></name><name><surname>Ward</surname><given-names>W. E.</given-names></name><name><surname>Peters</surname><given-names>S. J.</given-names></name></person-group><article-title>Increases in skeletal muscle ATGL and its inhibitor G0S2 following 8 weeks of endurance training in metabolically different rat skeletal muscles</article-title><source><italic>American Journal of Physiology. Regulatory, Integrative and Comparative Physiology</italic></source><year>2016</year><volume>310</volume><issue>2</issue><fpage>R125</fpage><lpage>R133</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00062.2015</pub-id><pub-id pub-id-type="other">2-s2.0-84983140107</pub-id><?supplied-pmid 26511521?><pub-id pub-id-type="pmid">26511521</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aquilano</surname><given-names>K.</given-names></name><name><surname>Baldelli</surname><given-names>S.</given-names></name><name><surname>La Barbera</surname><given-names>L.</given-names></name><name><surname>Lettieri Barbato</surname><given-names>D.</given-names></name><name><surname>Tatulli</surname><given-names>G.</given-names></name><name><surname>Ciriolo</surname><given-names>M. R.</given-names></name></person-group><article-title>Adipose triglyceride lipase decrement affects skeletal muscle homeostasis during aging through FAs-PPARalpha-PGC-1alpha antioxidant response</article-title><source><italic>Oncotarget</italic></source><year>2016</year><volume>7</volume><issue>17</issue><fpage>23019</fpage><lpage>23032</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.8552</pub-id><pub-id pub-id-type="other">2-s2.0-84966650439</pub-id><?supplied-pmid 27056902?><pub-id pub-id-type="pmid">27056902</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lass</surname><given-names>A.</given-names></name><name><surname>Zimmermann</surname><given-names>R.</given-names></name><name><surname>Haemmerle</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman syndrome</article-title><source><italic>Cell Metabolism</italic></source><year>2006</year><volume>3</volume><issue>5</issue><fpage>309</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2006.03.005</pub-id><pub-id pub-id-type="other">2-s2.0-33646128723</pub-id><pub-id pub-id-type="other">33646128723</pub-id><?supplied-pmid 16679289?><pub-id pub-id-type="pmid">16679289</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mason</surname><given-names>R. R.</given-names></name><name><surname>Meex</surname><given-names>R. C.</given-names></name><name><surname>Russell</surname><given-names>A. P.</given-names></name><name><surname>Canny</surname><given-names>B. J.</given-names></name><name><surname>Watt</surname><given-names>M. J.</given-names></name></person-group><article-title>Cellular localization and associations of the major lipolytic proteins in human skeletal muscle at rest and during exercise</article-title><source><italic>PloS One</italic></source><year>2014</year><volume>9</volume><issue>7, article e103062</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0103062</pub-id><pub-id pub-id-type="other">2-s2.0-84904663848</pub-id><pub-id pub-id-type="other">84904663848</pub-id><?supplied-pmid 25054327?><pub-id pub-id-type="pmid">25054327</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badin</surname><given-names>P. M.</given-names></name><name><surname>Loubiere</surname><given-names>C.</given-names></name><name><surname>Coonen</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Regulation of skeletal muscle lipolysis and oxidative metabolism by the co-lipase CGI-58</article-title><source><italic>Journal of Lipid Research</italic></source><year>2012</year><volume>53</volume><issue>5</issue><fpage>839</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1194/jlr.M019182</pub-id><pub-id pub-id-type="other">2-s2.0-84860290557</pub-id><pub-id pub-id-type="other">84860290557</pub-id><?supplied-pmid 22383684?><pub-id pub-id-type="pmid">22383684</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>P.</given-names></name><name><surname>Kadegowda</surname><given-names>A. K.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Muscle-specific deletion of comparative gene identification-58 (CGI-58) causes muscle steatosis but improves insulin sensitivity in male mice</article-title><source><italic>Endocrinology</italic></source><year>2015</year><volume>156</volume><issue>5</issue><fpage>1648</fpage><lpage>1658</lpage><pub-id pub-id-type="doi">10.1210/en.2014-1892</pub-id><pub-id pub-id-type="other">2-s2.0-84929009001</pub-id><pub-id pub-id-type="other">84929009001</pub-id><?supplied-pmid 25751639?><pub-id pub-id-type="pmid">25751639</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nur</surname><given-names>B. G.</given-names></name><name><surname>Gencpinar</surname><given-names>P.</given-names></name><name><surname>Yuzbasioglu</surname><given-names>A.</given-names></name><name><surname>Emre</surname><given-names>S. D.</given-names></name><name><surname>Mihci</surname><given-names>E.</given-names></name></person-group><article-title>Chanarin-Dorfman syndrome: genotype-phenotype correlation</article-title><source><italic>European Journal of Medical Genetics</italic></source><year>2015</year><volume>58</volume><issue>4</issue><fpage>238</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1016/j.ejmg.2015.01.011</pub-id><pub-id pub-id-type="other">2-s2.0-84929043470</pub-id><pub-id pub-id-type="other">84929043470</pub-id><?supplied-pmid 25682902?><pub-id pub-id-type="pmid">25682902</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langfort</surname><given-names>J.</given-names></name><name><surname>Ploug</surname><given-names>T.</given-names></name><name><surname>Ihlemann</surname><given-names>J.</given-names></name><name><surname>Saldo</surname><given-names>M.</given-names></name><name><surname>Holm</surname><given-names>C.</given-names></name><name><surname>Galbo</surname><given-names>H.</given-names></name></person-group><article-title>Expression of hormone-sensitive lipase and its regulation by adrenaline in skeletal muscle</article-title><source><italic>The Biochemical Journal</italic></source><year>1999</year><volume>340</volume><issue>Part 2</issue><fpage>459</fpage><lpage>465</lpage><?supplied-pmid 10333490?><pub-id pub-id-type="pmid">10333490</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langfort</surname><given-names>J.</given-names></name><name><surname>Ploug</surname><given-names>T.</given-names></name><name><surname>Ihlemann</surname><given-names>J.</given-names></name><name><surname>Holm</surname><given-names>C.</given-names></name><name><surname>Galbo</surname><given-names>H.</given-names></name></person-group><article-title>Stimulation of hormone-sensitive lipase activity by contractions in rat skeletal muscle</article-title><source><italic>The Biochemical Journal</italic></source><year>2000</year><volume>351</volume><issue>Part 1</issue><fpage>207</fpage><lpage>214</lpage><?supplied-pmid 10998363?><pub-id pub-id-type="pmid">10998363</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watt</surname><given-names>M. J.</given-names></name><name><surname>Holmes</surname><given-names>A. G.</given-names></name><name><surname>Pinnamaneni</surname><given-names>S. K.</given-names></name><etal/></person-group><article-title>Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue</article-title><source><italic>American Journal of Physiology. Endocrinology and Metabolism</italic></source><year>2006</year><volume>290</volume><issue>3</issue><fpage>E500</fpage><lpage>E508</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00361.2005</pub-id><pub-id pub-id-type="other">2-s2.0-33645093212</pub-id><?supplied-pmid 16188906?><pub-id pub-id-type="pmid">16188906</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C. W.</given-names></name></person-group><article-title>Lipid droplets, lipophagy, and beyond</article-title><source><italic>Biochimica et Biophysica Acta</italic></source><year>2016</year><volume>1861</volume><issue>8 Part B</issue><fpage>793</fpage><lpage>805</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2015.12.010</pub-id><pub-id pub-id-type="other">2-s2.0-84954286761</pub-id><?supplied-pmid 26713677?><pub-id pub-id-type="pmid">26713677</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vrablik</surname><given-names>T. L.</given-names></name><name><surname>Petyuk</surname><given-names>V. A.</given-names></name><name><surname>Larson</surname><given-names>E. M.</given-names></name><name><surname>Smith</surname><given-names>R. D.</given-names></name><name><surname>Watts</surname><given-names>J. L.</given-names></name></person-group><article-title>Lipidomic and proteomic analysis of Caenorhabditis elegans lipid droplets and identification of ACS-4 as a lipid droplet-associated protein</article-title><source><italic>Biochimica et Biophysica Acta</italic></source><year>2015</year><volume>1851</volume><issue>10</issue><fpage>1337</fpage><lpage>1345</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2015.06.004</pub-id><pub-id pub-id-type="other">2-s2.0-84937866913</pub-id><?supplied-pmid 26121959?><pub-id pub-id-type="pmid">26121959</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>S.</given-names></name><name><surname>Khaddaj</surname><given-names>R.</given-names></name><name><surname>Cottier</surname><given-names>S.</given-names></name><name><surname>Stradalova</surname><given-names>V.</given-names></name><name><surname>Jacob</surname><given-names>C.</given-names></name><name><surname>Schneiter</surname><given-names>R.</given-names></name></person-group><article-title>Mature lipid droplets are accessible to ER luminal proteins</article-title><source><italic>Journal of Cell Science</italic></source><year>2016</year><volume>129</volume><issue>20</issue><fpage>3803</fpage><lpage>3815</lpage><pub-id pub-id-type="doi">10.1242/jcs.189191</pub-id><pub-id pub-id-type="other">2-s2.0-84995475723</pub-id><pub-id pub-id-type="other">84995475723</pub-id><?supplied-pmid 27591256?><pub-id pub-id-type="pmid">27591256</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickel</surname><given-names>P. E.</given-names></name><name><surname>Tansey</surname><given-names>J. T.</given-names></name><name><surname>Welte</surname><given-names>M. A.</given-names></name></person-group><article-title>PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores</article-title><source><italic>Biochimica et Biophysica Acta</italic></source><year>2009</year><volume>1791</volume><issue>6</issue><fpage>419</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2009.04.002</pub-id><pub-id pub-id-type="other">2-s2.0-66349128492</pub-id><?supplied-pmid 19375517?><pub-id pub-id-type="pmid">19375517</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolins</surname><given-names>N. E.</given-names></name><name><surname>Brasaemle</surname><given-names>D. L.</given-names></name><name><surname>Bickel</surname><given-names>P. E.</given-names></name></person-group><article-title>A proposed model of fat packaging by exchangeable lipid droplet proteins</article-title><source><italic>FEBS Letters</italic></source><year>2006</year><volume>580</volume><issue>23</issue><fpage>5484</fpage><lpage>5491</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2006.08.040</pub-id><pub-id pub-id-type="other">2-s2.0-33749058310</pub-id><pub-id pub-id-type="other">33749058310</pub-id><?supplied-pmid 16962104?><pub-id pub-id-type="pmid">16962104</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolins</surname><given-names>N. E.</given-names></name><name><surname>Quaynor</surname><given-names>B. K.</given-names></name><name><surname>Skinner</surname><given-names>J. R.</given-names></name><name><surname>Schoenfish</surname><given-names>M. J.</given-names></name><name><surname>Tzekov</surname><given-names>A.</given-names></name><name><surname>Bickel</surname><given-names>P. E.</given-names></name></person-group><article-title>S3-12, adipophilin, and TIP47 package lipid in adipocytes</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2005</year><volume>280</volume><issue>19</issue><fpage>19146</fpage><lpage>19155</lpage><pub-id pub-id-type="doi">10.1074/jbc.M500978200</pub-id><pub-id pub-id-type="other">2-s2.0-21444437133</pub-id><pub-id pub-id-type="other">21444437133</pub-id><?supplied-pmid 15731108?><pub-id pub-id-type="pmid">15731108</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Xu</surname><given-names>G.</given-names></name><name><surname>Meng</surname><given-names>Q.</given-names></name></person-group><article-title>PLIN1 deficiency affects testicular gene expression at the meiotic stage in the first wave of spermatogenesis</article-title><source><italic>Gene</italic></source><year>2014</year><volume>543</volume><issue>2</issue><fpage>212</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2014.04.021</pub-id><pub-id pub-id-type="other">2-s2.0-84899902578</pub-id><pub-id pub-id-type="other">84899902578</pub-id><?supplied-pmid 24727056?><pub-id pub-id-type="pmid">24727056</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacPherson</surname><given-names>R. E.</given-names></name><name><surname>Peters</surname><given-names>S. J.</given-names></name></person-group><article-title>Piecing together the puzzle of perilipin proteins and skeletal muscle lipolysis</article-title><source><italic>Applied Physiology, Nutrition, and Metabolism</italic></source><year>2015</year><volume>40</volume><issue>7</issue><fpage>641</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1139/apnm-2014-0485</pub-id><pub-id pub-id-type="other">2-s2.0-84938489222</pub-id><pub-id pub-id-type="other">84938489222</pub-id><?supplied-pmid 25971423?><pub-id pub-id-type="pmid">25971423</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minnaard</surname><given-names>R.</given-names></name><name><surname>Schrauwen</surname><given-names>P.</given-names></name><name><surname>Schaart</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Adipocyte differentiation-related protein and OXPAT in rat and human skeletal muscle: involvement in lipid accumulation and type 2 diabetes mellitus</article-title><source><italic>The Journal of Clinical Endocrinology and Metabolism</italic></source><year>2009</year><volume>94</volume><issue>10</issue><fpage>4077</fpage><lpage>4085</lpage><pub-id pub-id-type="doi">10.1210/jc.2009-0352</pub-id><pub-id pub-id-type="other">2-s2.0-70349898598</pub-id><pub-id pub-id-type="other">70349898598</pub-id><?supplied-pmid 19602560?><pub-id pub-id-type="pmid">19602560</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacPherson</surname><given-names>R. E.</given-names></name><name><surname>Ramos</surname><given-names>S. V.</given-names></name><name><surname>Vandenboom</surname><given-names>R.</given-names></name><name><surname>Roy</surname><given-names>B. D.</given-names></name><name><surname>Peters</surname><given-names>S. J.</given-names></name></person-group><article-title>Skeletal muscle PLIN proteins, ATGL and CGI-58, interactions at rest and following stimulated contraction</article-title><source><italic>American Journal of Physiology. Regulatory, Integrative and Comparative Physiology</italic></source><year>2013</year><volume>304</volume><issue>8</issue><fpage>R644</fpage><lpage>R650</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00418.2012</pub-id><pub-id pub-id-type="other">2-s2.0-84878455001</pub-id><?supplied-pmid 23408028?><pub-id pub-id-type="pmid">23408028</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macpherson</surname><given-names>R. E.</given-names></name><name><surname>Vandenboom</surname><given-names>R.</given-names></name><name><surname>Roy</surname><given-names>B. D.</given-names></name><name><surname>Peters</surname><given-names>S. J.</given-names></name></person-group><article-title>Skeletal muscle PLIN3 and PLIN5 are serine phosphorylated at rest and following lipolysis during adrenergic or contractile stimulation</article-title><source><italic>Physiological Reports</italic></source><year>2013</year><volume>1</volume><issue>4, article e00084</issue><pub-id pub-id-type="doi">10.1002/phy2.84</pub-id><?supplied-pmid 24303154?><pub-id pub-id-type="pmid">24303154</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosma</surname><given-names>M.</given-names></name><name><surname>Hesselink</surname><given-names>M. K.</given-names></name><name><surname>Sparks</surname><given-names>L. M.</given-names></name><etal/></person-group><article-title>Perilipin 2 improves insulin sensitivity in skeletal muscle despite elevated intramuscular lipid levels</article-title><source><italic>Diabetes</italic></source><year>2012</year><volume>61</volume><issue>11</issue><fpage>2679</fpage><lpage>2690</lpage><pub-id pub-id-type="doi">10.2337/db11-1402</pub-id><pub-id pub-id-type="other">2-s2.0-84868020505</pub-id><pub-id pub-id-type="other">84868020505</pub-id><?supplied-pmid 22807032?><pub-id pub-id-type="pmid">22807032</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conte</surname><given-names>M.</given-names></name><name><surname>Vasuri</surname><given-names>F.</given-names></name><name><surname>Trisolino</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Increased Plin2 expression in human skeletal muscle is associated with sarcopenia and muscle weakness</article-title><source><italic>PloS One</italic></source><year>2013</year><volume>8</volume><issue>8</issue><fpage>p. e73709</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0073709</pub-id><pub-id pub-id-type="other">2-s2.0-84881572578</pub-id><pub-id pub-id-type="other">84881572578</pub-id><?supplied-pmid 23977392?><pub-id pub-id-type="pmid">23977392</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stout</surname><given-names>M. B.</given-names></name><name><surname>Justice</surname><given-names>J. N.</given-names></name><name><surname>Nicklas</surname><given-names>B. J.</given-names></name><name><surname>Kirkland</surname><given-names>J. L.</given-names></name></person-group><article-title>Physiological aging: links among adipose tissue dysfunction, diabetes, and frailty</article-title><source><italic>Physiology (Bethesda)</italic></source><year>2017</year><volume>32</volume><issue>1</issue><fpage>9</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1152/physiol.00012.2016</pub-id><?supplied-pmid 27927801?><pub-id pub-id-type="pmid">27927801</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinert</surname><given-names>M.</given-names></name><name><surname>Parker</surname><given-names>B. L.</given-names></name><name><surname>Chaudhuri</surname><given-names>R.</given-names></name><etal/></person-group><article-title>mTORC2 and AMPK differentially regulate muscle triglyceride content via perilipin 3</article-title><source><italic>Molecular Metabolism</italic></source><year>2016</year><volume>5</volume><issue>8</issue><fpage>646</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1016/j.molmet.2016.06.007</pub-id><pub-id pub-id-type="other">2-s2.0-84979695517</pub-id><pub-id pub-id-type="other">84979695517</pub-id><?supplied-pmid 27656402?><pub-id pub-id-type="pmid">27656402</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Covington</surname><given-names>J. D.</given-names></name><name><surname>Noland</surname><given-names>R. C.</given-names></name><name><surname>Hebert</surname><given-names>R. C.</given-names></name><etal/></person-group><article-title>Perilipin 3 differentially regulates skeletal muscle lipid oxidation in active, sedentary, and type 2 diabetic males</article-title><source><italic>The Journal of Clinical Endocrinology and Metabolism</italic></source><year>2015</year><volume>100</volume><issue>10</issue><fpage>3683</fpage><lpage>3692</lpage><pub-id pub-id-type="doi">10.1210/JC.2014-4125</pub-id><pub-id pub-id-type="other">2-s2.0-84943739935</pub-id><pub-id pub-id-type="other">84943739935</pub-id><?supplied-pmid 26171795?><pub-id pub-id-type="pmid">26171795</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos</surname><given-names>S. V.</given-names></name><name><surname>Turnbull</surname><given-names>P. C.</given-names></name><name><surname>MacPherson</surname><given-names>R. E.</given-names></name><name><surname>LeBlanc</surname><given-names>P. J.</given-names></name><name><surname>Ward</surname><given-names>W. E.</given-names></name><name><surname>Peters</surname><given-names>S. J.</given-names></name></person-group><article-title>Changes in mitochondrial perilipin 3 and perilipin 5 protein content in rat skeletal muscle following endurance training and acute stimulated contraction</article-title><source><italic>Experimental Physiology</italic></source><year>2015</year><volume>100</volume><issue>4</issue><fpage>450</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1113/expphysiol.2014.084434</pub-id><pub-id pub-id-type="other">2-s2.0-84925932882</pub-id><pub-id pub-id-type="other">84925932882</pub-id><?supplied-pmid 25663294?><pub-id pub-id-type="pmid">25663294</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>Y. K.</given-names></name><name><surname>Londos</surname><given-names>C.</given-names></name><name><surname>Raaka</surname><given-names>B. M.</given-names></name><name><surname>Dalen</surname><given-names>K. T.</given-names></name><name><surname>Kimmel</surname><given-names>A. R.</given-names></name></person-group><article-title>Perilipin family members preferentially sequester to either triacylglycerol-specific or cholesteryl-ester-specific intracellular lipid storage droplets</article-title><source><italic>Journal of Cell Science</italic></source><year>2012</year><volume>125</volume><issue>Part 17</issue><fpage>4067</fpage><lpage>4076</lpage><pub-id pub-id-type="doi">10.1242/jcs.104943</pub-id><pub-id pub-id-type="other">2-s2.0-84866143955</pub-id><?supplied-pmid 22685330?><pub-id pub-id-type="pmid">22685330</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pourteymour</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Langleite</surname><given-names>T. M.</given-names></name><etal/></person-group><article-title>Perilipin 4 in human skeletal muscle: localization and effect of physical activity</article-title><source><italic>Physiological Reports</italic></source><year>2015</year><volume>3</volume><issue>8</issue><pub-id pub-id-type="doi">10.14814/phy2.12481</pub-id><pub-id pub-id-type="other">2-s2.0-84958012016</pub-id><pub-id pub-id-type="other">84958012016</pub-id><?supplied-pmid 26265748?><pub-id pub-id-type="pmid">26265748</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolins</surname><given-names>N. E.</given-names></name><name><surname>Quaynor</surname><given-names>B. K.</given-names></name><name><surname>Skinner</surname><given-names>J. R.</given-names></name><etal/></person-group><article-title>OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization</article-title><source><italic>Diabetes</italic></source><year>2006</year><volume>55</volume><issue>12</issue><fpage>3418</fpage><lpage>3428</lpage><pub-id pub-id-type="doi">10.2337/db06-0399</pub-id><pub-id pub-id-type="other">2-s2.0-33845517481</pub-id><pub-id pub-id-type="other">33845517481</pub-id><?supplied-pmid 17130488?><pub-id pub-id-type="pmid">17130488</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurens</surname><given-names>C.</given-names></name><name><surname>Bourlier</surname><given-names>V.</given-names></name><name><surname>Mairal</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Perilipin 5 fine-tunes lipid oxidation to metabolic demand and protects against lipotoxicity in skeletal muscle</article-title><source><italic>Scientific Reports</italic></source><year>2016</year><volume>6</volume><fpage>p. 38310</fpage><pub-id pub-id-type="doi">10.1038/srep38310</pub-id><pub-id pub-id-type="other">2-s2.0-85003033662</pub-id><?supplied-pmid 27922115?><pub-id pub-id-type="pmid">27922115</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos</surname><given-names>S. V.</given-names></name><name><surname>MacPherson</surname><given-names>R. E.</given-names></name><name><surname>Turnbull</surname><given-names>P. C.</given-names></name><etal/></person-group><article-title>Higher PLIN5 but not PLIN3 content in isolated skeletal muscle mitochondria following acute in vivo contraction in rat hindlimb</article-title><source><italic>Physiological Reports</italic></source><year>2014</year><volume>2</volume><issue>10</issue><pub-id pub-id-type="doi">10.14814/phy2.12154</pub-id><pub-id pub-id-type="other">2-s2.0-84923384071</pub-id><pub-id pub-id-type="other">84923384071</pub-id><?supplied-pmid 25318747?><pub-id pub-id-type="pmid">25318747</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosma</surname><given-names>M.</given-names></name><name><surname>Sparks</surname><given-names>L. M.</given-names></name><name><surname>Hooiveld</surname><given-names>G. J.</given-names></name><etal/></person-group><article-title>Overexpression of PLIN5 in skeletal muscle promotes oxidative gene expression and intramyocellular lipid content without compromising insulin sensitivity</article-title><source><italic>Biochimica et Biophysica Acta</italic></source><year>2013</year><volume>1831</volume><issue>4</issue><fpage>844</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2013.01.007</pub-id><pub-id pub-id-type="other">2-s2.0-84873729674</pub-id><?supplied-pmid 23353597?><pub-id pub-id-type="pmid">23353597</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>L. A.</given-names></name><name><surname>Skinner</surname><given-names>J. R.</given-names></name><name><surname>Shew</surname><given-names>T. M.</given-names></name><name><surname>Pietka</surname><given-names>T. A.</given-names></name><name><surname>Abumrad</surname><given-names>N. A.</given-names></name><name><surname>Wolins</surname><given-names>N. E.</given-names></name></person-group><article-title>Perilipin 5-driven lipid droplet accumulation in skeletal muscle stimulates the expression of fibroblast growth factor 21</article-title><source><italic>Diabetes</italic></source><year>2015</year><volume>64</volume><issue>8</issue><fpage>2757</fpage><lpage>2768</lpage><pub-id pub-id-type="doi">10.2337/db14-1035</pub-id><pub-id pub-id-type="other">2-s2.0-84958012017</pub-id><pub-id pub-id-type="other">84958012017</pub-id><?supplied-pmid 25829453?><pub-id pub-id-type="pmid">25829453</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casas</surname><given-names>M.</given-names></name><name><surname>Figueroa</surname><given-names>R.</given-names></name><name><surname>Jorquera</surname><given-names>G.</given-names></name><name><surname>Escobar</surname><given-names>M.</given-names></name><name><surname>Molg&#x000f3;</surname><given-names>J.</given-names></name><name><surname>Jaimovich</surname><given-names>E.</given-names></name></person-group><article-title>IP(3)-dependent, post-tetanic calcium transients induced by electrostimulation of adult skeletal muscle fibers</article-title><source><italic>The Journal of General Physiology</italic></source><year>2010</year><volume>136</volume><issue>4</issue><fpage>455</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1085/jgp.200910397</pub-id><pub-id pub-id-type="other">2-s2.0-77957835651</pub-id><pub-id pub-id-type="other">77957835651</pub-id><?supplied-pmid 20837675?><pub-id pub-id-type="pmid">20837675</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos</surname><given-names>S. V.</given-names></name><name><surname>Turnbull</surname><given-names>P. C.</given-names></name><name><surname>MacPherson</surname><given-names>R. E.</given-names></name></person-group><article-title>Adipose tissue depot specific differences of PLIN protein content in endurance trained rats</article-title><source><italic>Adipocytes</italic></source><year>2016</year><volume>5</volume><issue>2</issue><fpage>212</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1080/21623945.2016.1157672</pub-id><?supplied-pmid 27386161?><pub-id pub-id-type="pmid">27386161</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacPherson</surname><given-names>R. E.</given-names></name><name><surname>Herbst</surname><given-names>E. A.</given-names></name><name><surname>Reynolds</surname><given-names>E. J.</given-names></name><name><surname>Vandenboom</surname><given-names>R.</given-names></name><name><surname>Roy</surname><given-names>B. D.</given-names></name><name><surname>Peters</surname><given-names>S. J.</given-names></name></person-group><article-title>Subcellular localization of skeletal muscle lipid droplets and PLIN family proteins OXPAT and ADRP at rest and following contraction in rat soleus muscle</article-title><source><italic>American Journal of Physiology. Regulatory, Integrative and Comparative Physiology</italic></source><year>2012</year><volume>302</volume><issue>1</issue><fpage>R29</fpage><lpage>R36</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00163.2011</pub-id><pub-id pub-id-type="other">2-s2.0-84255185211</pub-id><?supplied-pmid 22012700?><pub-id pub-id-type="pmid">22012700</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prats</surname><given-names>C.</given-names></name><name><surname>Donsmark</surname><given-names>M.</given-names></name><name><surname>Qvortrup</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Decrease in intramuscular lipid droplets and translocation of HSL in response to muscle contraction and epinephrine</article-title><source><italic>Journal of Lipid Research</italic></source><year>2006</year><volume>47</volume><issue>11</issue><fpage>2392</fpage><lpage>2399</lpage><pub-id pub-id-type="doi">10.1194/jlr.M600247-JLR200</pub-id><pub-id pub-id-type="other">2-s2.0-33845590561</pub-id><pub-id pub-id-type="other">33845590561</pub-id><?supplied-pmid 16905768?><pub-id pub-id-type="pmid">16905768</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roepstorff</surname><given-names>C.</given-names></name><name><surname>Vistisen</surname><given-names>B.</given-names></name><name><surname>Donsmark</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Regulation of hormone-sensitive lipase activity and Ser563 and Ser565 phosphorylation in human skeletal muscle during exercise</article-title><source><italic>The Journal of Physiology</italic></source><year>2004</year><volume>560</volume><issue>Part 2</issue><fpage>551</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2004.066480</pub-id><pub-id pub-id-type="other">2-s2.0-7444229976</pub-id><?supplied-pmid 15308678?><pub-id pub-id-type="pmid">15308678</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinnankoski-Tuikka</surname><given-names>R.</given-names></name><name><surname>Hulmi</surname><given-names>J. J.</given-names></name><name><surname>Torvinen</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Lipid droplet-associated proteins in high-fat fed mice with the effects of voluntary running and diet change</article-title><source><italic>Metabolism</italic></source><year>2014</year><volume>63</volume><issue>8</issue><fpage>1031</fpage><lpage>1040</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2014.05.010</pub-id><pub-id pub-id-type="other">2-s2.0-84904391834</pub-id><pub-id pub-id-type="other">84904391834</pub-id><?supplied-pmid 24972504?><pub-id pub-id-type="pmid">24972504</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espinosa</surname><given-names>A.</given-names></name><name><surname>Campos</surname><given-names>C.</given-names></name><name><surname>Diaz-Vegas</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Insulin-dependent H2O2 production is higher in muscle fibers of mice fed with a high-fat diet</article-title><source><italic>International Journal of Molecular Sciences</italic></source><year>2013</year><volume>14</volume><issue>8</issue><fpage>15740</fpage><lpage>15754</lpage><pub-id pub-id-type="doi">10.3390/ijms140815740</pub-id><pub-id pub-id-type="other">2-s2.0-84881139517</pub-id><pub-id pub-id-type="other">84881139517</pub-id><?supplied-pmid 23899788?><pub-id pub-id-type="pmid">23899788</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuramoto</surname><given-names>K.</given-names></name><name><surname>Okamura</surname><given-names>T.</given-names></name><name><surname>Yamaguchi</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Perilipin 5, a lipid droplet-binding protein, protects heart from oxidative burden by sequestering fatty acid from excessive oxidation</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2012</year><volume>287</volume><issue>28</issue><fpage>23852</fpage><lpage>23863</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.328708</pub-id><pub-id pub-id-type="other">2-s2.0-84863614584</pub-id><pub-id pub-id-type="other">84863614584</pub-id><?supplied-pmid 22532565?><pub-id pub-id-type="pmid">22532565</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boucher</surname><given-names>J.</given-names></name><name><surname>Kleinridders</surname><given-names>A.</given-names></name><name><surname>Kahn</surname><given-names>C. R.</given-names></name></person-group><article-title>Insulin receptor signaling in normal and insulin-resistant states</article-title><source><italic>Cold Spring Harbor Perspectives in Biology</italic></source><year>2014</year><volume>6</volume><issue>1</issue><pub-id pub-id-type="doi">10.1101/cshperspect.a009191</pub-id><pub-id pub-id-type="other">2-s2.0-84891648237</pub-id><pub-id pub-id-type="other">84891648237</pub-id><?supplied-pmid 24384568?><pub-id pub-id-type="pmid">24384568</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Summers</surname><given-names>S. A.</given-names></name><name><surname>Garza</surname><given-names>L. A.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Birnbaum</surname><given-names>M. J.</given-names></name></person-group><article-title>Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide</article-title><source><italic>Molecular and Cellular Biology</italic></source><year>1998</year><volume>18</volume><issue>9</issue><fpage>5457</fpage><lpage>5464</lpage><pub-id pub-id-type="doi">10.1128/MCB.18.9.5457</pub-id><pub-id pub-id-type="other">0031841949</pub-id><?supplied-pmid 9710629?><pub-id pub-id-type="pmid">9710629</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ragheb</surname><given-names>R.</given-names></name><name><surname>Shanab</surname><given-names>G. M.</given-names></name><name><surname>Medhat</surname><given-names>A. M.</given-names></name><name><surname>Seoudi</surname><given-names>D. M.</given-names></name><name><surname>Adeli</surname><given-names>K.</given-names></name><name><surname>Fantus</surname><given-names>I. G.</given-names></name></person-group><article-title>Free fatty acid-induced muscle insulin resistance and glucose uptake dysfunction: evidence for PKC activation and oxidative stress-activated signaling pathways</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>2009</year><volume>389</volume><issue>2</issue><fpage>211</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2009.08.106</pub-id><pub-id pub-id-type="other">2-s2.0-70349338611</pub-id><pub-id pub-id-type="other">70349338611</pub-id><?supplied-pmid 19706288?><pub-id pub-id-type="pmid">19706288</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senthivinayagam</surname><given-names>S.</given-names></name><name><surname>McIntosh</surname><given-names>A. L.</given-names></name><name><surname>Moon</surname><given-names>K. C.</given-names></name><name><surname>Atshaves</surname><given-names>B. P.</given-names></name></person-group><article-title>Plin2 inhibits cellular glucose uptake through interactions with SNAP23, a SNARE complex protein</article-title><source><italic>PloS One</italic></source><year>2013</year><volume>8</volume><issue>9</issue><fpage>p. e73696</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0073696</pub-id><pub-id pub-id-type="other">2-s2.0-84883612242</pub-id><pub-id pub-id-type="other">84883612242</pub-id><?supplied-pmid 24040030?><pub-id pub-id-type="pmid">24040030</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakke</surname><given-names>S. S.</given-names></name><name><surname>Feng</surname><given-names>Y. Z.</given-names></name><name><surname>Nikolic</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Myotubes from severely obese type 2 diabetic subjects accumulate less lipids and show higher lipolytic rate than myotubes from severely obese non-diabetic subjects</article-title><source><italic>PloS One</italic></source><year>2015</year><volume>10</volume><issue>3, article e0119556</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0119556</pub-id><pub-id pub-id-type="other">2-s2.0-84925438762</pub-id><pub-id pub-id-type="other">84925438762</pub-id><?supplied-pmid 25790476?><pub-id pub-id-type="pmid">25790476</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billecke</surname><given-names>N.</given-names></name><name><surname>Bosma</surname><given-names>M.</given-names></name><name><surname>Rock</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Perilipin 5 mediated lipid droplet remodelling revealed by coherent Raman imaging</article-title><source><italic>Integrative Biology (Camb)</italic></source><year>2015</year><volume>7</volume><issue>4</issue><fpage>467</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1039/C4IB00271G</pub-id><pub-id pub-id-type="other">2-s2.0-84927600418</pub-id><?supplied-pmid 25804837?><pub-id pub-id-type="pmid">25804837</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gemmink</surname><given-names>A.</given-names></name><name><surname>Bosma</surname><given-names>M.</given-names></name><name><surname>Kuijpers</surname><given-names>H. J.</given-names></name><etal/></person-group><article-title>Decoration of intramyocellular lipid droplets with PLIN5 modulates fasting-induced insulin resistance and lipotoxicity in humans</article-title><source><italic>Diabetologia</italic></source><year>2016</year><volume>59</volume><issue>5</issue><fpage>1040</fpage><lpage>1048</lpage><pub-id pub-id-type="doi">10.1007/s00125-016-3865-z</pub-id><pub-id pub-id-type="other">2-s2.0-84957640093</pub-id><pub-id pub-id-type="other">84957640093</pub-id><?supplied-pmid 26864436?><pub-id pub-id-type="pmid">26864436</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masiero</surname><given-names>E.</given-names></name><name><surname>Agatea</surname><given-names>L.</given-names></name><name><surname>Mammucari</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Autophagy is required to maintain muscle mass</article-title><source><italic>Cell Metabolism</italic></source><year>2009</year><volume>10</volume><issue>6</issue><fpage>507</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2009.10.008</pub-id><pub-id pub-id-type="other">2-s2.0-70449927247</pub-id><pub-id pub-id-type="other">70449927247</pub-id><?supplied-pmid 19945408?><pub-id pub-id-type="pmid">19945408</pub-id></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>A. D.</given-names></name><name><surname>Savage</surname><given-names>D. B.</given-names></name><name><surname>Siniossoglou</surname><given-names>S.</given-names></name></person-group><article-title>Lipid droplet-organelle interactions: emerging roles in lipid metabolism</article-title><source><italic>Current Opinion in Cell Biology</italic></source><year>2015</year><volume>35</volume><fpage>91</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2015.04.017</pub-id><pub-id pub-id-type="other">2-s2.0-84938699454</pub-id><pub-id pub-id-type="other">84938699454</pub-id><?supplied-pmid 25988547?><pub-id pub-id-type="pmid">25988547</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakellariou</surname><given-names>G. K.</given-names></name><name><surname>Pearson</surname><given-names>T.</given-names></name><name><surname>Lightfoot</surname><given-names>A. P.</given-names></name><etal/></person-group><article-title>Mitochondrial ROS regulate oxidative damage and mitophagy but not age-related muscle fiber atrophy</article-title><source><italic>Scientific Reports</italic></source><year>2016</year><volume>6</volume><fpage>p. 33944</fpage><pub-id pub-id-type="doi">10.1038/srep33944</pub-id><pub-id pub-id-type="other">2-s2.0-84995685486</pub-id><?supplied-pmid 27681159?><pub-id pub-id-type="pmid">27681159</pub-id></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarparanta</surname><given-names>J.</given-names></name><name><surname>Garcia-Macia</surname><given-names>M.</given-names></name><name><surname>Singh</surname><given-names>R.</given-names></name></person-group><article-title>Autophagy and mitochondria in obesity and type 2 diabetes</article-title><source><italic>Current Diabetes Reviews</italic></source><year>2016</year><volume>12</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.2174/1573399812666160217122530</pub-id><?supplied-pmid 26900135?><pub-id pub-id-type="pmid">26900135</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fealy</surname><given-names>C. E.</given-names></name><name><surname>Mulya</surname><given-names>A.</given-names></name><name><surname>Lai</surname><given-names>N.</given-names></name><name><surname>Kirwan</surname><given-names>J. P.</given-names></name></person-group><article-title>Exercise training decreases activation of the mitochondrial fission protein dynamin-related protein-1 in insulin-resistant human skeletal muscle</article-title><source><italic>Journal of Applied Physiology (Bethesda, Md.: 1985)</italic></source><year>2014</year><volume>117</volume><issue>3</issue><fpage>239</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01064.2013</pub-id><pub-id pub-id-type="other">2-s2.0-84905505470</pub-id><?supplied-pmid 24947026?><pub-id pub-id-type="pmid">24947026</pub-id></element-citation></ref><ref id="B110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>D.</given-names></name><name><surname>Nie</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>R.</given-names></name><name><surname>Zhai</surname><given-names>Y.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name></person-group><article-title>Comparative gene identification-58 (CGI-58) promotes autophagy as a putative lysophosphatidylglycerol acyltransferase</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2014</year><volume>289</volume><issue>47</issue><fpage>33044</fpage><lpage>33053</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.573857</pub-id><pub-id pub-id-type="other">2-s2.0-84911458356</pub-id><pub-id pub-id-type="other">84911458356</pub-id><?supplied-pmid 25315780?><pub-id pub-id-type="pmid">25315780</pub-id></element-citation></ref><ref id="B111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>X.</given-names></name><name><surname>Yuan</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Autophagy involved in lipopolysaccharide-induced foam cell formation is mediated by adipose differentiation-related protein</article-title><source><italic>Lipids in Health and Disease</italic></source><year>2014</year><volume>13</volume><fpage>p. 10</fpage><pub-id pub-id-type="doi">10.1186/1476-511X-13-10</pub-id><pub-id pub-id-type="other">2-s2.0-84892147134</pub-id><pub-id pub-id-type="other">84892147134</pub-id><?supplied-pmid 24405744?><pub-id pub-id-type="pmid">24405744</pub-id></element-citation></ref><ref id="B112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaushik</surname><given-names>S.</given-names></name><name><surname>Cuervo</surname><given-names>A. M.</given-names></name></person-group><article-title>AMPK-dependent phosphorylation of lipid droplet protein PLIN2 triggers its degradation by CMA</article-title><source><italic>Autophagy</italic></source><year>2016</year><volume>12</volume><issue>2</issue><fpage>432</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1080/15548627.2015.1124226</pub-id><pub-id pub-id-type="other">2-s2.0-84964495084</pub-id><?supplied-pmid 26902588?><pub-id pub-id-type="pmid">26902588</pub-id></element-citation></ref><ref id="B113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Kaushik</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Autophagy regulates lipid metabolism</article-title><source><italic>Nature</italic></source><year>2009</year><volume>458</volume><issue>7242</issue><fpage>1131</fpage><lpage>1135</lpage><pub-id pub-id-type="doi">10.1038/nature07976</pub-id><pub-id pub-id-type="other">2-s2.0-65949095803</pub-id><pub-id pub-id-type="other">65949095803</pub-id><?supplied-pmid 19339967?><pub-id pub-id-type="pmid">19339967</pub-id></element-citation></ref><ref id="B114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaushik</surname><given-names>S.</given-names></name><name><surname>Cuervo</surname><given-names>A. M.</given-names></name></person-group><article-title>Degradation of lipid droplet-associated proteins by chaperone-mediated autophagy facilitates lipolysis</article-title><source><italic>Nature Cell Biology</italic></source><year>2015</year><volume>17</volume><issue>6</issue><fpage>759</fpage><lpage>770</lpage><pub-id pub-id-type="doi">10.1038/ncb3166</pub-id><pub-id pub-id-type="other">2-s2.0-84930182353</pub-id><pub-id pub-id-type="other">84930182353</pub-id><?supplied-pmid 25961502?><pub-id pub-id-type="pmid">25961502</pub-id></element-citation></ref><ref id="B115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>E. A.</given-names></name><name><surname>Hargreaves</surname><given-names>M.</given-names></name></person-group><article-title>Exercise, GLUT4, and skeletal muscle glucose uptake</article-title><source><italic>Physiological Reviews</italic></source><year>2013</year><volume>93</volume><issue>3</issue><fpage>993</fpage><lpage>1017</lpage><pub-id pub-id-type="doi">10.1152/physrev.00038.2012</pub-id><pub-id pub-id-type="other">2-s2.0-84880949120</pub-id><pub-id pub-id-type="other">84880949120</pub-id><?supplied-pmid 23899560?><pub-id pub-id-type="pmid">23899560</pub-id></element-citation></ref><ref id="B116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kioumourtzoglou</surname><given-names>D.</given-names></name><name><surname>Gould</surname><given-names>G. W.</given-names></name><name><surname>Bryant</surname><given-names>N. J.</given-names></name></person-group><article-title>Insulin stimulates syntaxin4 SNARE complex assembly via a novel regulatory mechanism</article-title><source><italic>Molecular and Cellular Biology</italic></source><year>2014</year><volume>34</volume><issue>7</issue><fpage>1271</fpage><lpage>1279</lpage><pub-id pub-id-type="doi">10.1128/MCB.01203-13</pub-id><pub-id pub-id-type="other">2-s2.0-84895819025</pub-id><pub-id pub-id-type="other">84895819025</pub-id><?supplied-pmid 24469400?><pub-id pub-id-type="pmid">24469400</pub-id></element-citation></ref><ref id="B117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strauss</surname><given-names>J. A.</given-names></name><name><surname>Shaw</surname><given-names>C. S.</given-names></name><name><surname>Bradley</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Immunofluorescence microscopy of SNAP23 in human skeletal muscle reveals colocalization with plasma membrane, lipid droplets, and mitochondria</article-title><source><italic>Physiological Reports</italic></source><year>2016</year><volume>4</volume><issue>1</issue><pub-id pub-id-type="doi">10.14814/phy2.12662</pub-id><pub-id pub-id-type="other">2-s2.0-84987621870</pub-id><pub-id pub-id-type="other">84987621870</pub-id><?supplied-pmid 26733245?><pub-id pub-id-type="pmid">26733245</pub-id></element-citation></ref><ref id="B118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espinosa</surname><given-names>A.</given-names></name><name><surname>Henriquez-Olguin</surname><given-names>C.</given-names></name><name><surname>Jaimovich</surname><given-names>E.</given-names></name></person-group><article-title>Reactive oxygen species and calcium signals in skeletal muscle: a crosstalk involved in both normal signaling and disease</article-title><source><italic>Cell Calcium</italic></source><year>2016</year><volume>60</volume><issue>3</issue><fpage>172</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.ceca.2016.02.010</pub-id><pub-id pub-id-type="other">2-s2.0-84959564478</pub-id><pub-id pub-id-type="other">84959564478</pub-id><?supplied-pmid 26965208?><pub-id pub-id-type="pmid">26965208</pub-id></element-citation></ref><ref id="B119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanner</surname><given-names>J. T.</given-names></name><name><surname>Bruton</surname><given-names>J. D.</given-names></name><name><surname>Katz</surname><given-names>A.</given-names></name><name><surname>Westerblad</surname><given-names>H.</given-names></name></person-group><article-title>Ca(2+) and insulin-mediated glucose uptake</article-title><source><italic>Current Opinion in Pharmacology</italic></source><year>2008</year><volume>8</volume><issue>3</issue><fpage>339</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/j.coph.2008.01.006</pub-id><pub-id pub-id-type="other">2-s2.0-44649155764</pub-id><pub-id pub-id-type="other">44649155764</pub-id><?supplied-pmid 18321782?><pub-id pub-id-type="pmid">18321782</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>FA flux in skeletal muscle and role of perilipins. (a) Schematic representation of FA uptake and deposition in lipid droplets (LD). FA uptake is mediated by FAT/CD36, located in the plasmalemma. FATP1/4 are located in the plasmatic membrane and cooperate with FA intake and metabolism. Movement of CD36 to the plasmatic membrane and an increment in FATP1/4 can be triggered by insulin or contraction (green arrow, see text for details). Once inside the cell, FAs can be accumulated in LDs as acyl-glycerides (TAG, DAG). Perilipins (PLINs) coat the LD membrane, along with the lipases ATGL and HSL and the coactivator CGI-48. In response to contraction (green arrow), ATGL activity increases, as a result of dissociation from PLINs, while HSL is activated by PKA-dependent phosphorylation. This leads to increased FA flux to cytosol and mitochondria, undergoing further <italic>&#x003b2;</italic>-oxidation (<italic>&#x003b2;</italic>-ox) and ATP synthesis. (b) Main function of PLIN2 in skeletal muscle. PLIN2 coats LD and promotes FA intake, leading to increased size of LD. (c) PLIN3 is part of LD mitochondria contact sites, promoting efficient transfer of FA from LD to mitochondria for oxidation. (d) In cases of excess plasmatic FAs, such as obesity and T2DM, FAs uptake into skeletal muscle is increased. Higher levels of PLIN2 promote an increase in both size and number of LDs. Furthermore, increased levels of PLIN5 foster FA metabolization inside mitochondria.</p></caption><graphic xlink:href="JDR2017-1789395.001"/></fig></floats-group></article>